Content uploaded by Jacqueline R Bullis
Author content
All content in this area was uploaded by Jacqueline R Bullis on Apr 15, 2016
Content may be subject to copyright.
Clinical Psychological Science
2014, Vol. 2(3) 344 –365
© The Author(s) 2013
Reprints and permissions:
sagepub.com/journalsPermissions.nav
DOI: 10.1177/2167702613505532
cpx.sagepub.com
Theoretical/Methodological/Review Article
Throughout history, philosophers and researchers have
attempted to understand the nature of anxiety and its
disorders. As early as 450 BC, the relationship between
an individual’s discrete emotions in response to stressors
and his or her enduring proclivity for such experiences
was of interest. For example, the Roman philosopher
Cicero proposed a theory of emotion that distinguished
between the temporary emotional state of anxiety (angor)
and the enduring tendency to experience anxiety (anxi-
etas; Lewis, 1970). Furthermore, in perhaps one of the
best-known historical conceptualizations of anxiety,
Freud (1924) distinguished between objective anxiety
signaling the presence of an immediate threat (e.g., a
loaded gun pressed to the temple) and neurotic anxiety
generated when an individual’s defense mechanisms are
no longer able to successfully repress an early traumatic
experience, which results in a persistent state of distress
(Reiss, 1997). In this article, we review a variety of
research areas with the purpose of shifting focus from
the study of discrete anxiety, mood, and related disorders
as defined in the Diagnostic and Statistical Manual of
Mental Disorders (5th ed.; DSM-5; American Psychiatric
Association, APA, 2013) to a broader understanding of
emotional or internalizing disorders. In particular, we
seek to call attention to higher-order temperamental fac-
tors that may be a more appropriate target for assessment
and intervention than may symptom-level manifestations
of these traits. Although relevant higher-order tempera-
mental dimensions associated with the experience of fre-
quent and intense negative emotions have acquired a
number of labels, we focus on the construct of “neuroti-
cism” as the first (Eysenck, 1947) and still most popular
(Lahey, 2009) conception of this trait.
Neuroticism is typically defined as the tendency to
experience frequent and intense negative emotions in
505532CPXXXX10.1177/2167702613505532Barlow et al.The Nature, Diagnosis, and Treatment of Neuroticism
research-article2013
Corresponding Author:
David H. Barlow, Department of Psychology, Boston University, 648
Beacon St., 6th Floor, Boston, MA 02215
E-mail: dhbarlow@bu.edu
The Nature, Diagnosis, and Treatment of
Neuroticism: Back to the Future
David H. Barlow1, Shannon Sauer-Zavala1, Jenna R. Carl1,
Jacqueline R. Bullis1, and Kristen K. Ellard2,3
1Department of Psychology, Boston University; 2Massachusetts General Hospital, Boston,
Massachusetts; and 3Harvard Medical School
Abstract
We highlight the role of neuroticism in the development and course of emotional disorders and make a case for shifting
the focus of intervention to this higher-order dimension of personality. Recent decades have seen great emphasis
placed on differentiating disorders into Diagnostic and Statistical Manual of Mental Disorders diagnoses; however,
evidence has suggested that splitting disorders into such fine categories may be highlighting relatively trivial differences.
Emerging research on the latent structure of anxiety and mood disorders has indicated that trait neuroticism, cultivated
through genetic, neurobiological, and psychological factors, underscores the development of these disorders. We raise
the possibility of a new approach for conceptualizing these disorders—as emotional disorders. From a service-delivery
point of view, we explore the possibility that neuroticism may be more malleable than previously thought and may
possibly be amenable to direct intervention. The public-health implications of directly treating and even preventing
the development of neuroticism would be substantial.
Keywords
anxiety disorders, temperament/personality and psychopathology, comorbidity
Received 7/8/13; Revision accepted 8/13/13
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
The Nature, Diagnosis, and Treatment of Neuroticism 345
response to various sources of stress. These negative
emotions are usually broadly construed to include anxi-
ety, fear, irritability, anger, sadness, and so forth, but the
greatest focus has been on the experience of anxious or
depressive mood. Accompanying this exaggerated nega-
tive emotionality is the pervasive perception that the
world is a dangerous and threatening place, along with
beliefs about one’s inability to manage or cope with chal-
lenging events. These beliefs often are manifested in
terms of heightened focus on criticism, either self-gener-
ated or from others, as confirming a general sense of
inadequacy and perceptions of lack of control over
salient events (Barlow, 2002; L. A. Clark & Watson, 2008;
Eysenck, 1947; Goldberg, 1993).
The label neuroticism was first used by Eysenck
(1947) to describe this statistically derived personality
trait; Eysenck coined the term after the commonly used
clinical label at that time: neurosis—the early DSM cate-
gory comprising people with anxiety, depression, and
related disorders. Building on earlier work by Slater
(1943), who used the term neurotic constitution, Eysenck,
no fan of things Freudian even in the 1940s, regretted
employing this term and noted that “it would no doubt
be preferable in some ways to use a more neutral kind of
label” (p. 49). Nevertheless, he made it clear that indi-
viduals with the diagnosis of neurosis occupied the path-
ological extreme of the personality trait of neuroticism.
Eysenck also noted, in a prescient bit of writing, that
these two constructs could be relatively independent and
that “some so called ‘neurotic’ inmates (of a hospital)
show very little evidence of the ‘neurotic constitution’
and would likely be situated rather towards the normal
end of the distribution” (p. 48). He went on to theorize
that these individuals would have been subjected to
extreme life stress, whereas individuals high on the trait
of neuroticism would require relatively little life stress to
trigger neurosis, thereby clearly presaging the stress-dia-
thesis model of psychopathology.
Although the study of trait or temperament models of
anxiety and related negative emotions has continued for
decades, this literature has had decreasing influence on
nosological schemes. DSM-III (3rd ed.; APA, 1980) repre-
sented the advent of an objective, empirically based clas-
sification system for mental disorders; patients previously
receiving a diagnosis of neurosis were now classified
more narrowly into specific anxiety, depressive, and
related disorders. These new discrete diagnostic catego-
ries indeed had a meaningful impact on the development
of pharmacological and individual psychological treat-
ments, particularly for anxiety and mood disorders (e.g.,
Barlow et al., 1984). This approach allowed for the devel-
opment of interventions targeting specific forms of psy-
chopathology and the ability to evaluate treatment
response on the basis of discrete outcomes. Although this
“splitting” approach to nosology ensured high rates
of diagnostic reliability, there is evidence that it may
have come at the expense of validity; in other words,
the current diagnostic system may be overemphasizing
categories that are minor variations of a broader underly-
ing syndrome (T. A. Brown & Barlow, 2005, 2009).
Neuroticism, combined with other temperamental vari-
ables, likely represents this syndrome.
Despite the marked emphasis during the past 30 years
on discrete DSM-based categories of emotional disorders
and their treatment, a few investigators have continued to
focus attention on the existence and salience of broader
underlying syndromes. For example, Andrews (1990) and
Tyrer (1989) each argued for the existence of a “general
neurotic syndrome” as a more parsimonious and heuris-
tic account of emotional disorders. In addition, Lahey
(2009), summarizing the growing evidence for the pub-
lic-health significance of neuroticism, documented that
neuroticism is strongly associated with and predicts many
different mental and physical disorders, as well as treat-
ment seeking for not only mental disorders but also gen-
eral health services. Indeed, he underscored evidence
that neuroticism may act as a salient predictor of the
quality and longevity of our lives. Lahey called for a more
substantial focus on the nature and origins of neuroticism
and the mechanisms through which this trait is linked to
both mental and physical disorders. Moreover, Cuijpers et
al. (2010) examined the economic cost of the trait of neu-
roticism and found, in a large representative sample of
the Dutch population, that these economic costs were
enormous and exceeded costs of common mental disor-
ders. Cuijpers et al. noted that “we should start thinking
about interventions that focus not on each of the specific
negative outcomes of neuroticism but rather on the start-
ing point itself” (p. 1086).
The current review begins with a section highlighting
commonalities among the emotional disorders, including
high rates of comorbidity, broad rather than narrow treat-
ment responsiveness among comorbid disorders, and
shared neurobiological mechanisms. Next, we present
the emerging research on the latent structure of emo-
tional disorders that may underlie these observed com-
monalities followed by a brief description of theoretical
accounts of the origins of neuroticism or trait anxiety.
The following section describes common functional rela-
tionships in emotional disorders, particularly among
emotional expression, negative appraisals under stress,
and avoidance, as well as new approaches to conceptual-
izing these disorders and suggests the possibility of more
satisfying dimensional nosological and assessment
schemes. Finally, a review of diverse research on the mal-
leability of neuroticism in both normal and pathological
expressions sets the stage for a discussion of possible
new strategies for treatment and prevention that focus
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
346 Barlow et al.
not on individual negative outcomes of neuroticism
in the form of the DSM-defined emotional disorders
but, rather, on neuroticism itself as well as related
temperaments.
Commonalities and Dimensions Among
Anxiety and Related Disorders
Empirical conceptions of the anxiety and major emo-
tional disorders are emerging that underscore their com-
monalities (Barlow, 2002; T. A. Brown, 2007; T. A. Brown
& Barlow, 2009). Major developments in at least three
areas—high rates of comorbidity, broad treatment
response across comorbid disorders, and shared neuro-
biological mechanisms—support this conception. First,
studies of phenomenology and nosology with a particu-
lar focus on comorbidity have suggested considerable
overlap among disorders. At the diagnostic level, this
overlap is most evident in high rates of current and life-
time comorbidity (e.g., Allen et al., 2010; T. A. Brown,
Campbell, Lehman, Grisham, & Mancill, 2001; Kessler,
Berglund, & Demler, 2003; Kessler et al., 1996; Kessler
et al., 1998; Kessler et al., 2008). In a study of 1,127
patients presenting at the Center for Anxiety and Related
Disorders (CARD) at Boston University, 55% of patients
with a principal anxiety disorder had at least one addi-
tional anxiety or depressive disorder at the time of assess-
ment, and this rate increased to 76% when lifetime
diagnoses were considered (T. A. Brown et al., 2001). To
take one example, of 324 patients diagnosed with DSM-
IV-TR (4th ed., text rev.; APA, 2000) panic disorder with
or without agoraphobia, 60% met criteria for an addi-
tional anxiety or mood disorder, breaking down to 47%
with an additional anxiety disorder and 33% with an
additional mood disorder. When lifetime diagnoses were
considered, the percentages rose to 77% of the patients
experiencing any comorbid anxiety or mood disorder,
breaking down to 56% for an additional anxiety disorder
and 60% for a mood disorder. The principal diagnostic
categories of posttraumatic stress disorder and general-
ized anxiety disorder were associated with the highest
comorbidity rates. Similarly, Merikangas, Zhang, and
Aveneoli (2003) followed approximately 500 individuals
for 15 years and found that relatively few people suffered
from anxiety or depression alone; when patients did
meet criteria for a single disorder at one point in time, an
additional anxiety or depressive episode disorder almost
certainly emerged at a later time.
These summaries are most likely conservative as a
result of artifactual constraints in DSM-IV-TR (which were
continued in DSM-5), such as the nature of inclusion-
exclusion criteria used. For instance, when adhering
strictly to DSM-IV-TR diagnostic rules, the comorbidity
between dysthymia and generalized anxiety disorder in
the T. A. Brown et al. (2001) study was 5%. However,
when the hierarchical rule that generalized anxiety disor-
der should not be assigned when occurring exclusively
during a course of a mood disorder was suspended, the
comorbidity estimate increased to 90%. These data also
ignore the presence of subthreshold symptoms that did
not meet diagnostic thresholds for one disorder or
another.
Second, psychological treatments for a given anxiety
disorder often produce improvement in additional
comorbid anxiety or mood disorders that are not specifi-
cally addressed in treatment (Allen et al., 2010; Borkovec,
Abel, & Newman, 1995; T. A. Brown, Antony, & Barlow,
1995; Tsao, Lewin, & Craske, 1998; Tsao, Mystkowski, &
Zucker, 2002). For example, we examined the course of
additional diagnoses in a sample of 126 patients who
were being treated at CARD for panic disorder with or
without agoraphobia (T. A. Brown et al., 1995). A signifi-
cant pre- to posttreatment decline in overall comorbidity
was noted (40% to 17%, respectively). This effect could
represent the generalization of elements of treatment to
independent facets of both disorders or the effective tar-
geting of “core” features of emotional disorders. The fact
that a wide range of emotional disorders (e.g., major
depressive disorder, obsessive-compulsive disorder,
panic disorder) respond approximately equivalently to
antidepressant medications has also been interpreted by
some researchers as indicating shared features among
these disorders (e.g., Hudson & Pope, 1990).
There are several possible explanations for high rates
of comorbidity and overlapping treatment response that
we have reviewed extensively elsewhere (T. A. Brown &
Barlow, 2002, 2009), including overlapping definitional
criteria, artifactual reasons (e.g., differential base rates of
occurrence in our setting), and the possibility that disor-
ders are sequentially related such that the features of one
disorder act as risk factors for another disorder. Another
more intriguing explanation, noted earlier, is that this pat-
tern of comorbidity argues for the existence of what has
been called a general neurotic syndrome (Andrews, 1990,
1996; Tyrer, 1989). Under this conceptualization, hetero-
geneity in the expression of emotional disorder symp-
toms (e.g., individual differences in the prominence of
social anxiety, panic attacks, anhedonia) is regarded as
trivial variation in the manifestation of a broader syn-
drome. We return to this argument later.
Third, recent research from affective neuroscience has
suggested the existence of a biological syndrome that is
common across emotional disorders. For example,
research among individuals with anxiety and related dis-
orders has suggested that hyperexcitability of limbic
structures, along with limited inhibitory control by corti-
cal structures, may be one explanation for the increased
negative emotionality among individuals with such
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
The Nature, Diagnosis, and Treatment of Neuroticism 347
diagnoses (Etkin & Wager, 2007; Mayberg et al., 1999;
Porto et al., 2009; Shin & Liberzon, 2010). Specifically,
increased “bottom-up” processing through amygdala
overactivation, coupled with inefficient or deregulated
cortical inhibition of amygdala responses, has been
shown in studies of social anxiety disorder (Lorberbaum
et al., 2004; Phan, Fitzgerald, Nathan, & Tancer, 2006;
Tillfors, Furmark, Marteinsdottir, & Fredrikson, 2002),
posttraumatic stress disorder (Shin et al., 2005), general-
ized anxiety disorder (Etkin, Prater, Hoeft, Menon, &
Schatzberg, 2010; Hoehn-Saric, Schlund, & Wong, 2004;
Paulesu et al., 2010), specific phobia (Paquette et al.,
2003; Straube, Mentzel, & Miltner, 2006), and depression
(Holmes et al., 2012). This same amygdala overactivation
has also been found in individuals high in the personality
dimension of neuroticism (Keightley et al., 2003). Of
course, a few unique and idiosyncratic neurobiological
factors have also been associated with discrete DSM-IV-
TR diagnoses (Blair et al., 2008; Chorpita, Albano, &
Barlow, 1998), but it seems likely that the broader based
genetic and neurobiological commonalities reviewed
earlier may better account for the nature of emotional
disorders. Although these three commonalities among
emotional disorders have garnered attention, a recent
focus on the hierarchical structure of emotional disorders
may be more heuristic.
Latent Temperamental Structure of
Emotional Disorders
Emerging research on the latent dimensional features of
emotional disorders has revealed a hierarchical structure
that places emphasis on two genetically based core
dimensions of temperament: neuroticism and, to a lesser
degree, extraversion (Barlow, 2002). Extraversion, com-
monly associated with social qualities, broadly refers to
an energetic approach to the world, including activity
and positive emotionality in addition to sociability.
Although these traits have received various labels, includ-
ing negative affect, behavioral inhibition, trait anxiety,
and harm avoidance as alternate terms for neuroticism
and positive affect or behavioral activation as alternate
terms for extraversion, substantial existing literature has
underscored the roles of these constructs in accounting
for the onset, overlap, and maintenance of anxiety,
depressive, and related disorders (T. A. Brown, 2007;
T. A. Brown & Barlow, 2009; T. A. Brown, Chorpita, &
Barlow, 1998; Gershuny & Sher, 1998; Griffith et al., 2010;
Kasch, Rottenberg, Arnow, & Gotlib, 2002; Kessler et al.,
2011; Krueger, 1999; Watson, Clark, & Carey, 1988).
The study of trait or temperament models of anxiety
and related negative emotions has been ongoing for
decades in spite of the decreasing influence of this work
on nosological schemes. It is interesting that almost every
theory of personality structure references neuroticism-
and extraversionlike traits, which suggests the fundamen-
tal importance of these dimensions for functioning (John
& Srivastava, 1999). Current well-accepted personality
conceptualizations, such as the Big Three (Eysenck &
Eysenck, 1975; Tellegen, 1985; Watson & Clark, 1993) and
the Big Five (Digman, 1990; John, 1990; McCrae & Costa,
1987), prominently feature these dimensions of personal-
ity despite disagreement on additional traits (e.g., con-
straint in the Big Three and agreeableness, openness,
and conscientiousness in the Big Five) and different
methods of formulation.
In addition to understanding the structure of personal-
ity, researchers have been interested in the neurobiologi-
cal basis for such traits. Eysenck’s (1961, 1981) influential
theory led to the development of the Big Three, and he
was the first to implicate neuroticism and extraversion.
He based his trait theory on variations in levels of cortical
activation and autonomic nervous system reactivity and
suggested that extraversion/positive emotion is associ-
ated with moderate levels of arousal, whereas neuroti-
cism/negative emotion is associated with under- or
overarousal. A number of researchers have examined the
relationship of neuroticism (and extraversion) in the
development of anxiety and other negative emotions. For
example, Gershuny and Sher (1998) found, in a sample
composed of 466 young adults, that the combination of
high neuroticism and low extraversion at Time 1 seemed
to play an important and predisposing role in the emer-
gence of anxiety assessed 4 years later.
Further bolstering the importance of neuroticism and
extraversion in the experience of negative emotion, Gray
(1982; Gray & McNaughton, 1996) described a similar
trait theory and its neurobiological correlates that map
onto Eysenck’s (1961, 1981) traits, namely, the behavioral
inhibition system, behavioral approach system, and fight-
flight system. In Gray’s theory, the biological basis for
anxiety is the behavioral inhibition system’s (over)reac-
tion to novel signals or punishment with exaggerated
inhibition. High levels on Gray’s behavioral inhibition
system roughly relate to high levels of neuroticism and
low levels of extraversion in Eysenck’s model, and the
behavioral approach system roughly corresponds to high
extraversion and low neuroticism (Barlow, 2002). The
fight-flight system involves unconditioned escape behav-
ior (i.e., flight) and defensive aggression (i.e., fight) in
response to unconditioned punishment, such as pain,
and unconditioned frustrative nonrewards (Gray, 1991;
Gray & McNaughton, 1996). As such, the fight-flight sys-
tem may represent a biological vulnerability specifically
to the distinct emotion of fear/panic, as opposed to anxi-
ety more generally.
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
348 Barlow et al.
In another trait theory, Kagan (1989, 1994) examined
children’s approach-and-withdrawal behavior and cre-
ated profiles characterizing their levels of behavioral inhi-
bition. Kagan’s (1989) definition of behavioral inhibition
is similar to Gray’s (1982) in that it involves a low thresh-
old for limbic arousal and uncertainty regarding unfamil-
iar events. Kagan considered these stable profiles as
representing temperaments; physiological (increased
salivary cortisol levels and muscle tension, greater pupil
dilation, and elevated urinary catecholamine levels) and
external (subsequent development of anxiety disorders)
correlates of behavioral inhibition have also been found
(Biederman et al., 1993; Hirshfeld-Becker et al., 1992).
Robinson, Kagan, Reznick, and Corley (1992) suggested
that temperament is clearly heritable; however, only 30%
of individuals who clearly met criteria for behavioral inhi-
bition as young children went on to develop anxiety dis-
orders (Biederman, Rosenbaum, Hirshfeld, & Faraone,
1990). Moreover, temperament (as described in Kagan
& Snidman, 1991) appears to be somewhat malleable,
which suggests that environmental factors are also impor-
tant determinants in temperament and anxiety vulnera-
bility. These findings support the notion of a “constraining”
biological vulnerability (in contrast to a “determining”
role of temperament) in the development of anxiety in
adolescence and adulthood, a theme to which we return
in our later discussion of treatment.
Finally, in one of the best known modern conceptual-
izations of temperaments related to anxiety and depres-
sion, L. A. Clark and Watson (1991) proposed two
genetically based core dimensions, neuroticism/negative
emotionality and extraversion/positive emotionality, as
part of their tripartite theory (L. A. Clark, 2005; L. A. Clark,
Watson, & Mineka, 1994; Watson, 2005). These concepts,
originally based on Eysenck’s (1961, 1981) model, are
also closely related to Gray’s (1982) constructs of behav-
ioral inhibition and behavioral activation both conceptu-
ally and empirically. Although the traits reviewed earlier
may turn out to be distinct in some way, current evidence
in this area from CARD and elsewhere (L. A. Clark, 2005;
Watson, 2005) lump these concepts together in a partially
heritable temperament that we have labeled neuroticism/
behavioral inhibition (or just neuroticism1) and behav-
ioral activation/positive affect (T. A. Brown, 2007; T. A.
Brown & Barlow, 2009; T. A. Brown et al., 1998; Campbell-
Sills, Liverant, & Brown, 2004).
We have been studying the latent structure of emo-
tional disorders for the past 20 years (e.g., T. A. Brown
et al., 1998; Zinbarg & Barlow, 1996) and have confirmed,
with some modifications, the tripartite model of emo-
tional disorders first proposed by L. A. Clark and Watson
(1991). For example, the findings from T. A. Brown et al.
(1998), which used a sample composed of 350 patients
with DSM-IV-TR anxiety and mood disorders, confirmed
a hierarchical structure. In this structure, neuroticism and
extraversion emerged as higher-order factors to the DSM-
IV-TR disorder factors, with significant paths from neu-
roticism to each of the five DSM-IV-TR factors. In accord
with a reformulated hierarchical model of anxiety and
depression (Mineka, Watson, & Clark, 1998), results
showed that extraversion was predictive of unipolar
depression and social anxiety disorder only (see also
T. A. Brown & McNiff, 2009). In addition, Rosellini,
Lawrence, Meyer, and Brown (2010) found recently that
agoraphobia (but not panic disorder) was associated
with low extraversion, which provided support for the
change in DSM-5 that separates agoraphobia from panic
disorder as a distinct, new, diagnosis. In this model, auto-
nomic arousal, which we consider to reflect largely the
phenomenon of panic, emerges as a lower-order factor
with significant paths from panic disorder and general-
ized anxiety disorder, which demonstrated a negative
relationship with autonomic surges.
These findings on latent structure have recently been
extended both by our research team (T. A. Brown, 2007;
T. A. Brown & Barlow, 2009) and by other researchers
(e.g., Griffith et al., 2010; Kessler et al., 2011). For exam-
ple, Griffith et al. (2010), studying a large sample of eth-
nically diverse adolescents and including both self-report
and peer-report measures of neuroticism, found that a
single internalizing factor was common to lifetime diag-
noses of mood and anxiety disorders and that this inter-
nalizing factor was all but isomorphic with neuroticism.
Noting the replication of earlier findings (e.g., T. A.
Brown et al., 1998), Griffith et al. suggested that these
results provided further evidence that neuroticism may
be the core of “internalizing” disorders. Using factor anal-
ysis, Krueger (1999) similarly found that the variance in
seven anxiety and mood disorders can be accounted for
by the higher-order dimension of internalizing/neuroti-
cism. Although the key features of the DSM anxiety and
mood disorders (i.e., the specific symptoms used to dis-
criminate between diagnoses) cannot be collapsed indis-
criminately into higher-order temperamental dimensions,
it seems safe to conclude, on the basis of these studies,
that what is common outweighs what is not. Thus, virtu-
ally all of the considerable covariance among latent vari-
ables corresponding to the DSM-IV-TR constructs of
depression, social anxiety disorder, generalized anxiety
disorder, obsessive-compulsive disorder, and panic disor-
der was explained by the higher-order dimension of neu-
roticism (and extraversion); bipolar disorder was not
included in these studies.
Our own framework for understanding the origins of
neuroticism as well as emotional disorders describes
three separate but interacting diatheses or vulnerabilities
(i.e., triple vulnerability theory; Barlow, 1988, 2000;
Barlow, Ellard, Sauer-Zavala, Bullis, & Carl, 2013). We
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
The Nature, Diagnosis, and Treatment of Neuroticism 349
have explicated these vulnerabilities in some detail else-
where (Barlow et al., 2013) but included a general bio-
logical (heritable) vulnerability common across disorders,
a general psychological vulnerability consisting of a
heightened sense of unpredictability and uncontrollabil-
ity and associated changes in brain function resulting
from adverse early experiences, and a more specific psy-
chological vulnerability, also largely learned, accounting
for why one particular emotional disorder may emerge
instead of another. It seems increasingly evident that the
two generalized vulnerabilities identified in the triple vul-
nerability theory are implicated in the development and
expression of neuroticism itself (T. A. Brown, 2007; T. A.
Brown & Barlow, 2009). Indeed, we hypothesize that
these two generalized vulnerabilities function as direct
risk factors for the development of neuroticism, which in
turn mediates risk for the development of anxiety and
mood disorders. What is notable for our purposes is that
adverse experiences contribute strongly to changes in
brain function and that later experiences may alter result-
ing temperamental expression and associated brain cir-
cuits (Kagan & Snidman, 1991; Nemeroff, 2013).
The Nature of Emotional Disorders
Negative reactivity to emotional experience appears fun-
damentally connected to neuroticism and resulting emo-
tional disorder pathology. Emotional disorder is a term
that has been used to group anxiety, unipolar mood, and
related disorders, such as somatoform and dissociative
disorders (Barlow, 1991; Barlow et al., 2011; T. A. Brown
& Barlow, 2009). These disorders are characterized by a
number of shared emotional disturbances, which appear
to be closely linked to neuroticism. As described earlier,
individuals with emotional disorders, compared with
healthy individuals, have higher levels of negative affect
(e.g., T. A. Brown & Barlow, 2009) and report experienc-
ing more frequent and intense negative emotions
(Campbell-Sills, Barlow, Brown, & Hofman, 2006; Mennin,
Heimberg, Turk, & Fresco, 2005). In addition, individuals
with emotional disorders, compared with healthy indi-
viduals, report less emotional clarity (Baker, Holloway,
Thomas, Thomas, & Owens, 2004; McLaughlin, Mennin,
& Farach, 2007; Tull & Roemer, 2007; Weiss et al., 2012)
and acceptance of emotional experiences (McLaughlin et
al., 2007; Tull & Roemer, 2007; Weiss et al., 2012) and
find the experience of negative emotions more unpleas-
ant (Roemer, Salters, Raffa, & Orsillo, 2005).
In view of these reactions to negative emotions, it is
not surprising that individuals with emotional disorders
also display a range of cognitive and behavioral strate-
gies aimed at reducing encounters with or the impact
of negative emotions. Individuals with emotional disor-
ders exhibit early vigilant information-processing biases
toward negative information, but then they tend to
quickly turn their attention away from such negative
information (MacLeod & Mathews, 2012; Mathews &
MacLeod, 2005). These individuals also react strongly to
negative emotions when they occur with attempts to sup-
press or avoid the emotional experience (Aldao, Nolen-
Hoeksema, & Schweizer, 2010; Baker et al., 2004; Moore,
Zoellner, & Mollenholt, 2008; Tull & Roemer, 2007; Turk,
Heimberg, Luterek, Mennin, & Fresco, 2005). In addition,
individuals with emotional disorders, compared with
healthy individuals, display greater intolerance for uncer-
tainty, ambiguity, or situations that are perceived as uncon-
trollable, which leads to heightened negative affect. For
example, intolerance of uncertainty and distress have been
demonstrated across a range of disorders, including
depression, generalized anxiety disorder, and social anxi-
ety disorder (Boelen, Vrinssen, & van Tulder, 2010;
Boswell, Thompson-Hollands, Farchione, & Barlow, 2013;
Lee, Orsillo, Roemer, & Allen, 2010; Tolin, Abramowitz,
Brigidi, & Foa, 2003). Increased perceptions of emotions
as uncontrollable and intolerable as well as increased
attempts at emotional control are also evident across dis-
orders. A wide range of research has suggested that these
ways of interpreting and responding to negative emotions
paradoxically serve to increase and maintain negative
emotions and emotional disorder symptomatology. Thus,
we consider this pathological reaction to emotional expe-
rience as the phenotypic core of emotional disorders. The
following section discusses in detail the nature of these
response tendencies and their sequelae.
Evidence has suggested that how one interprets or
reacts to negative emotions when they occur can affect
the intensity and duration of the emotional experience
(Sauer & Baer, 2009; Sauer-Zavala et al., 2012). A clear
example of how this process unfolds can be seen in early
models of panic disorder (Barlow, 1988; D. M. Clark,
1986). In these models, physical symptoms associated
with initial panic attacks (e.g., increased heart rate) evoke
anxiety about impending consequences (e.g., heart
attack), which intensifies anxiety and its related physical
symptoms and possibly triggers additional panic attacks.
It is important to note that in individuals without panic
disorder, occasional panic attacks do not evoke strong
emotional reactions (nonclinical panic; Bouton, Mineka,
& Barlow, 2001). Thus, the central issue in panic disorder
is not the experience of panic attacks but the negative
emotional reaction to the intense fear (panic) itself.
Negative reactions or interpretations of emotions that
intensify the experience are also prominent in other anxi-
ety and depressive disorders. For example, in research on
obsessive-compulsive disorder, Rachman and de Silva
(1978) found that the content of ego-dystonic intrusive
thoughts under stress are similar in patients diagnosed
with obsessive-compulsive disorder and nonclinical
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
350 Barlow et al.
control participants, which supports the notion that the
way these thoughts are interpreted and managed has
implications for the development of this emotional disor-
der. In addition, individuals with generalized anxiety dis-
order may find unexpected, uncontrolled emotional
reactions that result from unplanned or mildly threaten-
ing situations particularly aversive and may engage in
worry or checking behavior to regulate this emotional
experience (Newman & Llera, 2011). Once again, the
focus of an emotional disorder (panic attacks, intrusive
thoughts, and social evaluation) may be determined by
early learning experiences; however, the negative emo-
tional reaction itself and one’s attempts to cope with or
downregulate this emotional reaction are at the core of
the disorder.
Several constructs capturing the problematic reactions
to emotions that may be implicated in the transdiagnostic
development and maintenance of emotional disorders
have been identified; specifically, these constructs mea-
sure the tendency of individuals to find emotional experi-
ences aversive and, as such, engage in attempts to avoid
them. Anxiety sensitivity, defined as a propensity for
developing beliefs that anxiety-related symptoms will
have negative somatic, cognitive, and social conse-
quences (Reiss, 1991), is one such construct. Anxiety sen-
sitivity represents an individual’s characteristic way of
evaluating and responding to an emotional experience
(specifically anxiety) when it occurs, distinct from the
frequency or intensity of anxiety itself (Cox, Taylor, &
Enns, 1999; Lilienfeld, 1999). Although anxiety sensitivity
was originally introduced as a risk factor for panic disor-
der (Reiss, Peterson, Gursky, & McNally, 1986) and has
predominantly been studied in the context of this disor-
der (e.g., Maller & Reiss, 1992; Plehn & Peterson, 2002;
Rassovsky, Kushner, Schwarze, & Wangensteen, 2000), a
large literature also has implicated anxiety sensitivity in
the development of other anxiety disorders and depres-
sion (see Boswell, Farchione, et al., 2013; Naragon-
Gainey, 2010; Taylor, 1999).
For example, prospective studies have demonstrated
that anxiety sensitivity predicts the onset of anxiety and
depressive disorders (Maller & Reiss, 1992; Schmidt,
Keough, Timpano, & Richey, 2008) beyond the contribu-
tions of the tendency to experience anxiety (see McNally,
1996, for a review) and that reductions in anxiety sensi-
tivity during treatment predict symptom improvement
(Gallagher et al., 2013). In addition, anxiety sensitivity
has demonstrated incremental validity above trait neu-
roticism in the prediction of most mood and anxiety dis-
orders (Collimore, McCabe, Carelton, & Asmundson,
2008; Cox, Enns, Walker, Kjernisted, & Pidlubny, 2001;
Kotov, Watson, Robles, & Schmidt, 2007; Norton et al.,
1997; Reardon & Williams, 2007). These results support
the notion that how one relates to negative emotions is
just as important in the development of emotional
disorders as is the frequency and intensity of emotional
experience.
Another transdiagnostic construct that has been impli-
cated in the development and maintenance of emotional
disorders is experiential avoidance, defined as the unwill-
ingness to remain in contact with uncomfortable internal
experience (e.g., thoughts, emotions, sensations, memo-
ries, urges) through escape or avoidance (Hayes, Wilson,
Gifford, Follette, & Strosahl, 1996). Self-report studies
have demonstrated that individuals with anxiety disor-
ders (Begotka, Woods, & Wetterneck, 2004; Hayes,
Luoma, Bond, Masuda, & Lillis, 2006; Kashdan, Breen,
Afram, & Terhar, 2010) and depressive disorders (Berking,
Neacsiu, Comtois, & Linehan, 2009; Hayes et al., 2006;
Shahar & Herr, 2011; Tull, Gratz, Salters, & Roemer, 2004)
display high levels of self-reported experiential avoid-
ance. The existing literature also has suggested that expe-
riential avoidance both predicts generalized anxiety
disorder symptoms even when the variance associated
with frequency of negative affect is parceled out (Lee
et al., 2010) and mediates the relationship between neu-
roticism and posttraumatic stress disorder symptoms
(Maack, Tull, & Gratz, 2012; Pickett, Lodis, Parkhill, &
Orcutt, 2012). Furthermore, Cheavens and Heiy (2011)
recently found that avoidant coping partially mediates
the relationship between the experience of negative
emotions and major depressive symptoms among indi-
viduals high in experiential avoidance. Taken together,
these findings suggest that emotional disorder symptoms
are not simply a product of high levels of negative affect;
instead, the combination of strong negative emotions and
how one relates to them when they occur appears to be
important for the development of these disorders.
Individuals with emotional disorders also show defi-
cits in mindfulness (Cheavens et al., 2005; Hayes et al.,
1996), a related construct that refers to attention and
awareness toward the present moment in an accepting
manner regardless of how unpleasant the experience
(Kabat-Zinn, 1982). Studies have shown that deficits in
mindfulness are common across the emotional disorders
(Baer, Smith, Hopkins, Kritemeyer, & Toney, 2006;
K. Brown & Ryan, 2003; Cash & Whittingham, 2010;
Rasmussen & Pidgeon, 2011), which supports the case
for similar underlying constructs in these disorders.
Results of a recent study on the effects of dispositional
mindfulness on response to a laboratory stressor sug-
gested that individuals reporting higher levels of mindful-
ness display lower levels of self-reported anxiety and an
attenuated cortisol response than do individuals endors-
ing lower levels of this construct (K. Brown, Weinstein, &
Creswell, 2011). The impact of mindfulness on stress-
related cortisol secretion has been associated with atten-
uated amygdala activation in response to threat (Creswell,
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
The Nature, Diagnosis, and Treatment of Neuroticism 351
Way, Eisenberger, & Leiberman, 2007). Consistent with
data on experiential avoidance, results from studies have
suggested that the degree to which one responds to neg-
ative emotions in a mindful manner predicts psychologi-
cal symptoms over and above the contributions of a
traitlike tendency to experience negative emotions (Sauer
& Baer, 2009; Segal, Williams, & Teasdale, 2002).
Evidence has suggested that many of the maladaptive
behaviors associated with emotional disorders serve a
function of facilitating escape or avoidance of intense
emotions. Such behaviors include overt situational avoid-
ance as well as more subtle forms of avoidance and safety
behaviors. For example, situational avoidance is a hall-
mark feature of social anxiety disorder, specific phobias,
posttraumatic stress disorder, depression, agoraphobia,
and panic disorder (APA, 2013). Subtle forms of avoid-
ance are also typical across most emotional disorders. In
generalized anxiety disorder and obsessive-compulsive
disorder, engaging in worry or compulsions (Newman &
Llera, 2011), respectively, are subtle ways of avoiding the
distress associated with experiencing anxiety. In social
anxiety, subtle avoidance can include behaviors such as
decreased eye contact or standing farther away from peo-
ple during conversations or safety behaviors, such as
engaging in social interactions only with a close friend
present. In panic disorder, subtle avoidance includes
avoiding activities that produce anxietylike sensations,
such as exercise or drinking coffee (i.e., interoceptive
avoidance). Safety behaviors across disorders include car-
rying around medications or even empty medication bot-
tles, making sure to always have a cell phone or water on
hand, or engaging in certain activities only with a “safe”
person.
Addressing such behavioral avoidance is an important
element of most cognitive-behavioral treatments for emo-
tional disorders, such as through use of fear and avoid-
ance hierarchies in anxiety disorder protocols or activity
scheduling in depression treatments. Some treatment
protocols posit behavioral avoidance as comprising the
core of the dysfunction, as in the example of behavioral
activation, a well-supported treatment for depression,
which is based on the notion that depressive symptoms
are maintained by chronic avoidance of engagement or
activity (Manos, Kanter, & Busch, 2010).
In addition to engaging in problematic avoidant
behaviors, individuals with emotional disorders engage
in cognitive coping motivated by avoidance. Such pro-
cesses include emotion suppression and rumination.
Emotion suppression is a strategy in which individuals
deliberately attempt to push unpleasant, emotion-induc-
ing cognitions out of awareness; paradoxically, this strat-
egy has been shown to produce rebound effects in which
the suppressed thoughts return with greater frequency
and intensity (Rassin, Muris, Schmidt, & Merkelbach,
2000; Wegner, Schneider, Carter, & White, 1987). High
levels of emotion suppression have been demonstrated
across emotional disorders, including depression, gener-
alized anxiety disorder, obsessive-compulsive disorder,
and posttraumatic stress disorder (Purdon, 1999), and
have also been shown to exacerbate symptoms
(Abramowitz, Tolin, & Street, 2001). In particular, emo-
tional suppression has been associated with increased
physiological arousal (Hofmann, Heering, Sawyer, &
Asnaani, 2009). It is hypothesized that emotion suppres-
sion, like other forms of avoidance, is a negatively rein-
forced behavior that produces short-term reductions in
negative affect, despite then spawning increased negative
emotions in the longer term.
Rumination refers to repetitively and passively focus-
ing on negative mood and its possible causes, meanings,
and consequences (Nolen-Hoeksema, 1991). Like sup-
pression, rumination can be conceptualized as an avoid-
ant strategy because passive focus on surface matters
may serve to protect individuals from more distressing
concerns (Lyubomirsky & Nolen-Hoeksema, 1995;
Lyubomirsky, Tucker, Caldwell, & Berg, 1999). Rumination
has been shown to intensify negative affect (Nolen-
Hoeksema, Wisco, & Lyubomirsky, 2008), which leads to
more rumination, in what Selby, Anestis, and Joiner
(2008) described as an emotional cascade; this process
continues until a maladaptive behavior (reassurance
seeking, substance use, binge eating, etc.) interrupts the
cycle. Rumination appears to be prominent across emo-
tional disorders (see Aldao et al., 2010) and prospectively
predicts increases in anxiety and depressive symptoms
(Butler & Nolen-Hoeksema, 1994; Calmes & Roberts,
2007; Hong, 2007; Nolen-Hoeksema, 2000; Nolen-
Hoeksema, Larson, & Grayson, 1999; O’Connor,
O’Connor, & Marshall, 2007; Sarin, Abela, & Auerbach,
2005; Segerstrom, Tsao, Alden, & Craske, 2000).
It seems clear that negative reactions to strong emo-
tions lead to similar forms of avoidant cognitive coping
(e.g., emotion suppression and rumination) common to
all emotional disorders. These strategies that intensify
already strong negative emotions appear to lead to
greater use of disorder-specific behavioral coping.
Overall, the literature has suggested that individuals with
emotional disorders experience strong negative emotions
with frequency and evaluate these experiences as aver-
sive. As a result of these negative reactions to their emo-
tions, such individuals are more likely to engage in
avoidant coping strategies to manage emotional experi-
ences, and these strategies, in turn, paradoxically increase
the frequency/intensity of negative emotions. Once
again, we suggest that this functional relationship, driven
by neuroticism, is at the core of disorders of emotion.
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
352 Barlow et al.
Neuroticism/Trait Anxiety, Nosology,
and Dimensional Diagnosis of
Emotional Disorders
It was long thought that DSM-IV-TR represented the
zenith of a splitting approach to nosology we described
earlier and that began in the 1980s with the publication
of DSM-III, an approach basically unchanged in DSM-5.
The advent of an objective empirically based system of
classification of mental disorders was an enormous
advance over previous systems based on unsupported
etiological theories best exemplified by the term neuro-
sis. Beginning in the 1980s, with the splitting of neuroses
into anxiety, depressive, somatoform, and related disor-
ders, meaningful research on outcomes of pharmacologi-
cal and individual psychological treatments, particularly
cognitive-behavioral therapy, targeting these disorders
appeared (e.g., Barlow et al., 1984). It also became clear
at that time, on the basis of the pioneering work of Strupp
(1973), that clinical trials require the generation of
detailed individual therapeutic protocols to specify an
independent variable. As a result, these psychotherapeu-
tic treatments were increasingly characterized by well-
articulated individual protocols targeted to specific forms
of psychopathology as articulated in DSM-III and its suc-
cessors, particularly anxiety and depressive disorders.
These treatments were then evaluated empirically and
found efficacious in a variety of formats, uses, and set-
tings (Barlow, 1996, 2004, 2008; Barlow, Gorman, Shear,
& Woods, 2000; Heimberg, Liebowitz, & Hope, 1998;
Nathan & Gorman, 2007).
It is fair to say that these findings have had a substan-
tial impact in that public-health authorities have allocated
billions of dollars for training and dissemination of these
treatments (McHugh & Barlow, 2010). This approach to
nosology also has ensured high rates of diagnostic reli-
ability; however, as mentioned earlier, there was growing
suspicion both that advances in classification and treat-
ment development represented by this approach came at
the expense of diagnostic validity and that the current
system may be overemphasizing categories that are minor
variations of broader underlying syndromes. The careful
consideration of these broader underlying syndromes as
a conceptual approach to nosology would not imply a
return to a nonempirical system of classification based on
theories of etiology. Rather, this thinking points to a
quantitative approach using structural equation modeling
to examine the full range of anxiety and mood disorders
without the constraints of artificial categories, given their
strong relationship and potential overlap. Thus, our
evolving view is that DSM-5 emotional disorder catego-
ries do not qualify in any sense as real entities (Kendell,
1975) but do seem to be useful concepts or constructs
that emerge as “blips” on a general background of tem-
perament. The conceptualization of emotional disorders
in a more dimensional fashion should result in a more
satisfactory representation of salient aspects of these dis-
orders that would eliminate vexing issues of comorbidity.
But moving from this conceptualization to a dimensional
system of diagnostic assessment with implications for
treatment has proven an exceedingly difficult task even
in areas such as personality disorders in which there is
widespread agreement that this would be the preferred
approach (Widiger & Crego, 2013). The recent failure to
accomplish this goal in DSM-5 underscores these
difficulties.
In a preliminary attempt to conceptualize how this
effort might work for emotional disorders, we proposed
a dimensional classification scheme to reflect the research
described earlier (T. A. Brown & Barlow, 2009). The pur-
pose would be to create a profile that may provide a
more complete portrayal of a patient’s clinical presenta-
tion than would a more categorical approach that often
consists of several individual comorbid diagnoses. The
profile would highlight levels of constructs thought to be
important in forming a useful case conceptualization,
including neuroticism, extraversion (referred to as behav-
ioral activation/positive affectivity in this model), avoid-
ance, mood, and specific foci of anxiety (e.g., panic and
other autonomic surges, somatic symptoms, intrusive
cognitions, social evaluation, and trauma). Scores on the
dimension of trait neuroticism, arguably the most impor-
tant construct in this model, reflect the frequency, inten-
sity, and distress associated with negative emotions, as
well as perceptions of uncontrollability regarding future
challenges and low self-efficacy regarding one’s ability to
cope. The higher-order dimension of extraversion/posi-
tive affect is also represented because low levels of this
trait are specifically associated with major depressive dis-
order, social anxiety disorder, and agoraphobia, whereas
high levels are associated with euthymic states of bipolar
and cyclothymic disorders. As highlighted earlier, indi-
viduals with high levels of neuroticism are likely to dis-
play avoidance behaviors. In this dimensional system,
avoidance is broken into two types: behavioral/intero-
ceptive and cognitive/emotional.
Specific examples of disorder profiles highlight the
heuristic clinical value associated with dimensional clas-
sification of emotional disorders. For example, individu-
als with a principal diagnosis of panic disorder would
likely display profiles with high levels of neuroticism,
avoidance, and preoccupation with panic/autonomic
arousal and other somatic symptoms. In contrast, patients
presenting with posttraumatic stress disorder might dis-
play high neuroticism and preoccupation with panic/
autonomic arousal (flashbacks) and past trauma. Although
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
The Nature, Diagnosis, and Treatment of Neuroticism 353
each diagnostic category is linked to a prototypic dimen-
sional profile, this classification system would allow clini-
cians to determine the extent to which other key features
are present that would potentially affect treatment plan-
ning. A new measure, the multidimensional emotional
disorder inventory (MEDI), recently was developed to
assess these important vulnerabilities and characteristics
of emotional disorders with a single assessment tool; the
ongoing MEDI validation study has suggested that this
measure may be a reliable and valid method for assessing
important emotional disorder dimensions (Rosellini,
2013). A representation of what a MEDI profile might look
like is shown in Figure 1. These data present clinical esti-
mates of constructs composing the dimensional scheme
from a patient seen at CARD with a principal diagnosis of
posttraumatic stress disorder (motor vehicle accident) and
additional diagnoses of generalized anxiety disorder and
subclinical depression. Under the current diagnostic sys-
tem, unless a patient meets full diagnostic criteria for a
comorbid disorder, information on the dimensions not
associated with the primary diagnosis are discarded.
Given that the rates of comorbidity among emotional dis-
orders are high, with even greater overlap at the subclini-
cal level (T. A. Brown & Barlow 2009), a dimensional
classification system would allow for the integration of
several important areas of functioning.
Malleability of Neuroticism
The evidence regarding the malleability of personality
traits over time or in response to therapeutic intervention
is mixed. As noted earlier, Kagan (1989, 1994) described
his conceptualization of behavioral inhibition as strongly
heritable and stable; however, empirical evidence, includ-
ing Kagan’s own work, has suggested that only 30% of
children who clearly met criteria for this trait as young
children went on to develop anxiety disorders, although
some of the participants may have remained shy. Several
additional studies have yielded similar results (e.g.,
Hayward, Killen, Kraemer, & Taylor, 1998; Hirshfeld-
Becker et al., 2007; Schwartz, Snidman, & Kagan, 1999).
These results led Kagan to view behavioral inhibition as
a constraining factor subject to environmental influences.
Such influences may include stress and having parents
diagnosed with anxiety disorders; behaviorally inhibited
third to sixth graders were more likely to experience
increased anxiety if they reported more daily hassles
(Brozina & Abela, 2006) and were more likely to be diag-
nosed with an anxiety disorder if their parents also expe-
rienced such disorders (Biederman et al., 2001).
L. A. Clark (2009) has reviewed research examining
stability and change in personality disorders in adults.
Contrary to the thinking of most personality theorists, as
well as a statement in the DSM-5, which holds that per-
sonality traits are stable, inflexible, and pervasive, is
Clark’s observation that the collection of traits and behav-
iors that make up the definition of most personality dis-
orders do change, albeit slowly over time, with the
greatest change occurring in the behavioral manifesta-
tions of these traits. Furthermore, researchers examining
longitudinal changes in negative traits, such as neuroti-
cism, in the normal population have observed gradual
0
10
20
30
40
50
60
70
80
90
100
A/N BA/P DEP MAN SOM PAS IC SOC TRM AV-BI AV-CE
Score
Fig. 1. Example profile of patient evaluated with a dimensional classification system. Higher scores on
the y-axis indicate higher levels of the x-dimension; otherwise, the y-axis metric is arbitrary and used for
illustrative purposes. A/N = anxiety/neuroticism; BA/P = behavioral activation/positive affect; DEP = uni-
polar depression; MAN = mania; SOM = somatic anxiety; PAS = panic and related autonomic surges; IC =
intrusive cognitions; SOC = social evaluation; TRM = past trauma; AV-BI = behavioral and interoceptive
avoidance; AV-CE = cognitive and emotional avoidance.
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
354 Barlow et al.
age-related decreases that continue long into old age
(Roberts & Mroczeck, 2008; Roberts, Walton, & Viechtbauer,
2006). Similar age-related decreases in the related higher-
order construct of internalizing have also been found; spe-
cifically, internalizing means and indicator intercepts were
lower for older-aged cohorts (Eaton, Krueger, & Oltmanns,
2011; Oltmanns & Balsis, 2011). This pattern of results is
found at the mean level, which suggests that, summed
across individuals, neuroticism decreases across time. In
addition, change in neuroticism has been examined at the
individual level using growth modeling (Mroczek & Spiro,
2003); results suggested that there is great variability in
extent of change on temperamental variables, with some
people remaining at stable levels and other people chang-
ing a great deal (Helson, Jones, & Kwan, 2002; Small,
Hertzog, Hultsch, & Dixon, 2003).
At CARD, we have also investigated longitudinal
change in neuroticism, with particular focus on respon-
siveness to psychological intervention, and have encoun-
tered mixed findings. For example, in a study on the
treatment of panic disorder (T. A. Brown & Barlow, 1995),
comorbid anxiety and depressive diagnoses improved
immediately after successful treatment even though they
were not specifically targeted, which suggests, as
described earlier, the existence of an underlying temper-
amental vulnerability. But at a 2-year follow-up, comor-
bid diagnoses had returned to a level (30%) that was no
longer significantly different from pretreatment. This
result occurred despite the fact that, in the aggregate,
patients maintained or improved on gains for panic
disorder across the follow-up interval, which indicates
considerable independence between panic disorder
symptoms and related comorbidity. Although speculative,
and contrary to the more usual interpretations offered
earlier, these findings may suggest that current cognitive-
behavioral treatments are generally effective in address-
ing the specific symptoms and maintaining processes of
the targeted disorder (in this case, panic disorder) both
immediately and at follow-up but do not result in sub-
stantial reductions in general predispositional features
(e.g., neuroticism), which leaves patients vulnerable to
the emergence or persistence of other disorders. These
findings also raise the possibility that current psychologi-
cal treatments have become overly specialized because
they focus on disorder-specific features, such as panic
attacks in panic disorder or rituals connected to obses-
sional thought in obsessive-compulsive disorder, neglect-
ing broader dimensions that might produce more
favorable long-term outcomes across all disorders.
In a more direct evaluation of this issue, the temporal
stability (8 months) and predictive utility of self-reported
levels of neuroticism and extraversion in 41 individuals
diagnosed with major depressive disorder (most of whom
received some kind of treatment during this time) has
also been examined (Eaton et al., 2011; Oltmanns &
Balsis, 2011). Low levels of extraversion at Time 1 pre-
dicted poorer clinical outcome of major depressive disor-
der at the 8-month reassessment. Moreover, neuroticism
and extraversion were remarkably stable over time,
despite changes in clinical state. In fact, although more
than one third of depressed participants were classified
as no longer depressed at the 8-month follow-up, neu-
roticism and extraversion displayed the same high level
of temporal stability in this group as in a subgroup of
participants who were depressed at both assessment
points. Despite these overall findings, because there was
no information available regarding what types of treat-
ment patients received during this study, it is difficult to
determine how specific treatments may have affected the
temperamental constructs.
In contrast, other researchers have indeed found
changes in neuroticism as a function of time and treat-
ment. For example, we examined the temporal course
and temporal structural relationships of dimensions of
temperament (neuroticism, extraversion) within DSM-IV-
TR disorder constructs of depression, social anxiety dis-
order, and generalized anxiety disorder (T. A. Brown,
2007; T. A. Brown & Barlow, 2009). Outpatients with
these disorders (N = 606) were first examined at intake
and then reassessed at 1- and 2-year follow-ups. The
majority (76%) of patients received some kind of treat-
ment after intake, although not all at CARD, of varying
duration and quality. The overall rate of diagnosed anxi-
ety and mood disorders declined significantly during
follow-up from 100% at intake to 58% at the 2-year fol-
low-up. Despite the marked decline in DSM-IV-TR diag-
noses by the 2-year follow-up, test-retest correlations of
the factors and unconditional latent growth models indi-
cated that extraversion evidenced a very high degree of
temporal stability, consistent with its conceptualization as
a trait vulnerability construct that is relatively unaffected
by treatment. However, of the five constructs examined,
neuroticism evidenced the greatest amount of temporal
change and was the dimension associated with the larg-
est treatment effect. In addition to its inconsistency with
some prior research, such as that reviewed earlier (e.g.,
Kasch et al., 2002), this finding is clearly at odds with
conceptual assumptions that core dimensions of temper-
ament are stable, inflexible, and more resistant to psy-
chological treatment.
Levels of neuroticism and extraversion have also been
explored in a more specified context across a large ran-
domized controlled trial of cognitive therapy compared
with placebo for adults with major depressive disorder
(Tang et al., 2009). Results indicated that cognitive ther-
apy produced greater changes in both neuroticism and
extraversion than did placebo, but contrary to T. A.
Brown’s (2007) results, cognitive therapy maintained a
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
The Nature, Diagnosis, and Treatment of Neuroticism 355
significant effect only for extraversion after controlling
for changes in depression symptoms during treatment.
Nevertheless, the Tang et al. (2009) study differs from
Brown’s study in the clinical features of the sample (pure
major depressive disorder vs. heterogeneous anxiety and
unipolar depressive disorders) and the degree of control
provided regarding the treatment condition (placebo
controlled and with stringent adherence/fidelity proce-
dures vs. naturalistic, heterogeneous treatment).
There is also evidence that neuroticism may operate
differently than the DSM-IV-TR disorder constructs in sev-
eral ways (T. A. Brown, 2007). For instance, uncondi-
tional latent growth models of each DSM-IV-TR disorder
construct revealed inverse relations between the inter-
cept and the slope; that is, higher initial disorder severity
was associated with greater change over time. However,
the intercept and the slope of neuroticism were positively
correlated (r = .47), which indicated that patients with
higher initial levels of neuroticism tended to show less
change in this dimension over time, and, conversely,
patients with lower initial levels of neuroticism tended to
evidence greater change. Thus, unlike the DSM-IV-TR dis-
orders, the stability of neuroticism increased as a function
of initial severity. In addition, parallel-process latent
growth models indicated that higher initial levels of neu-
roticism were associated with less change in the DSM-IV-
TR constructs of generalized anxiety disorder and social
anxiety disorder. Although neuroticism alone demon-
strated no temporal relation with depression, the pres-
ence of chronic stress moderated the relationship such
that high neuroticism resulted in less improvement in
depression as the level of chronic stress increased (T. A.
Brown & Rosellini, 2011). These results are consistent
with results from earlier work, as well as theory, that
showed that neuroticism has directional temporal effects
on Axis I psychopathology (cf. Gershuny & Sher, 1998;
Kasch et al., 2002; Meyer, Johnson, & Winters, 2001) but
that the converse does not seem to occur; that is, initial
levels of the DSM-IV-TR disorders did not predict increases
in temperament over time.
Finally, evidence has suggested that change in DSM
disorder constructs (e.g., depression, social anxiety disor-
der, and generalized anxiety disorder) is significantly
related to change in neuroticism (T. A. Brown, 2007). Of
particular interest is the finding that all the temporal
covariance of the DSM-IV-TR disorder constructs was
accounted for by change in neuroticism; that is, when
neuroticism was specified as a predictor, there was no
temporal overlap among disorder constructs. The corre-
lational nature of these findings precludes firm conclu-
sions about the direction of these effects. Nevertheless,
and counter to some earlier evidence and conceptualiza-
tions (T. A. Brown et al., 1995; Kasch et al., 2002), all of
these findings suggest that neuroticism may be therapeu-
tically malleable, and it is this malleability that mediates
the extent of change in the emotional disorders.
Some authors have suggested that decreases in neu-
roticism over time may partly reflect the fact that mea-
sures of temperament overlap to some degree with
symptomatic measures of anxiety and depression, which
results in distortions on estimates of temperament (mood-
state distortion; cf. L. A. Clark, Vittengl, Kraft, & Jarrett,
2003; Jylhä & Isometsä, 2006; Widiger, Verheul, & van
den Brink, 1999). That is, the measurement of neuroti-
cism consists of some combination of stable tempera-
mental variance (i.e., vulnerability) and variability
attributable to generalized distress that would be subject
to greater temporal fluctuation and would imply that
neuroticism is apt to covary with temporal fluctuations in
the severity of disorders. However, results from a recent
study have suggested that measures of neuroticism (and
extraversion) primarily capture true temperamental vari-
ance even in individuals with emotional disorders
(Naragon-Gainey, Gallagher, & Brown, 2013). In addi-
tion, a number of longitudinal studies have controlled for
the periodic occurrence of anxious or depressive symp-
toms and still found that neuroticism acted independently
in predicting anxiety and mood (Lahey, 2009; Spijker, de
Graf, Oldehinkel, Nolen, & Ormel, 2007).
In sum, the malleability of neuroticism and other tem-
peramental variables, particularly in response to treat-
ment, remains an unsettled question. The studies
described earlier, in which researchers have examined
changes in temperamental variables in the context of
naturalistic treatments or treatments targeting disorder-
specific symptoms, have yielded mixed findings. In some
studies, temperament dimensions appeared to change
during the course of treatment in the expected directions
(e.g., T. A. Brown, 2007; Kennedy, Rapee, & Edwards,
2009), whereas in other studies, no changes in tempera-
ment occurred (e.g., Kasch et al., 2002). Inconsistencies
also exist in the degree to which the different dimensions
of temperament respond to treatment across studies.
Indeed, the research reviewed raises questions about the
nature and mechanisms of change of temperament dur-
ing treatment of emotional disorders, how best to mea-
sure temperament, and whether directly targeting
temperament therapeutically would lead to more defini-
tive results.
Prevention and Treatment of
Neuroticism
In most of the studies in which researchers have exam-
ined changes in temperament in response to psychologi-
cal interventions, including the studies described in the
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
356 Barlow et al.
previous section, researchers have not provided a priori
hypotheses regarding how and why the study treatment
might affect temperament other than as a by-product of
symptom reduction. The interventions used were not
designed to target features of temperament but, rather, to
address symptoms. Within such studies, it is difficult to
interpret changes in temperament. One explanation for
the mixed findings across studies is that there may be
specific interactions between the intervention and
the dimensions of temperament that influence which
temperament variables respond and to what extent. Such
interactions have been largely unexplored in studies of
psychological-treatment outcomes. However, recent
research from pharmacological-treatment studies has sup-
ported this treatment-temperament interaction hypothe-
sis, and emerging research from our own laboratory has
suggested that dimensions of temperament can be more
directly targeted through specialized treatments. In this
section, we review recent evidence for treatments specifi-
cally designed to affect temperament and discuss briefly
our own efforts to develop a psychological treatment
focused on directly addressing neurotic temperament.
Most of the studies in which researchers examine
interventions specifically designed to target temperament
have come from the literature on psychopharmacology
(for a review, see Soskin, Carl, Alpert, & Fava, 2012).
Results from these studies have provided some evidence
for specific interactions between treatment agents and
temperament variables. To summarize, this research has
indicated that serotonergic drug agents (i.e., selective
serotonin reuptake inhibitors) produce dampening
effects on neuroticism (Fu et al., 2004; Harmer et al.,
2009; Harmer, Mackay, Reid, Cowen, & Goodwin, 2006;
Murphy, Yiend, Lester, Cowen, & Harmer, 2009; Quilty,
Meusel, & Bagby, 2008) and possibly to a lesser extent on
extraversion (McCabe, Mishor, Cowen, & Harmer, 2010),
whereas catecholaminergic (i.e., noradrenergic/dopami-
nergic) agents produce specific enhancement of extraver-
sion (McCabe et al., 2010; Tomarken, Dichter, Freid,
Addington, & Shelton, 2004). The specific neurobiologi-
cal properties of these agents have been hypothesized to
mediate such observed effects on temperament variables.
For example, serotonergic agents have been shown to
decrease hyperreactivity of the amygdala in response to
fear-inducing stimuli and to inhibit dopaminergic neuro-
transmission in areas of the prefrontal cortex. In contrast,
catecholaminergic agents upregulate noradrenergic and
dopaminergic neurotransmission, particularly within the
mesolimbic reward circuitry (Soskin et al., 2012). Despite
the obvious differences between pharmacological and
psychological treatments, the studies on preferential
effects of pharmacological agents on dimensions of tem-
perament have provided some support for the notion
that treatments can be designed to selectively target tem-
peramental variables. As a corollary, the pharmacologic
results also suggested that treatments, whether pharma-
cological or psychological, should not be expected to
produce equivalent changes in temperament. Some treat-
ments may produce no effects on temperament, whereas
other treatments may produce generalized or specific
effects on dimensions of temperament.
Behavioral interventions designed to specifically
address temperamental vulnerabilities are limited in num-
ber. Rapee, Kennedy, Ingram, Edwards, and Sweeney’s
(2005) intervention for children identified as behaviorally
inhibited was designed with the purpose of preventing
the later onset of anxiety and related disorders and serves
as one example. The program consists of a parent-focused
intervention that includes psychoeducation about the
nature of anxiety, traditional cognitive-behavioral strate-
gies (i.e., exposure and cognitive restructuring) directed
toward personal concerns, and training in behavior man-
agement techniques that prevent an overprotective par-
enting style. Results from randomized controlled trials
(Rapee et al., 2005; Rapee, Kennedy, Ingram, Edwards &
Sweeney, 2010) have indicated that this program is clearly
successful at preventing anxiety disorders, but for our
purposes, the most interesting findings are those on the
effects of the program on temperament.
Specifically, using a brief version of this program,
Rapee et al. (2010) found that levels of behavioral inhibi-
tion did not differ significantly on the basis of either par-
ent report or laboratory observation, despite the success
in preventing the later onset of anxiety disorders.
However, when the program was administered in a more
intensive format with higher risk children, compared
with a group that did not receive the treatment, reduc-
tions in measures of temperament did occur (Kennedy
et al., 2009). Rapee et al. also noted that differences
among groups seemed to increase with time, which sug-
gested to them that interventions directed at tempera-
ment (and related risk factors) might produce an
increasing trajectory of change in temperament over the
years, at least in children.
In addition, some work has been conducted in an
effort to identify intervention strategies specifically for
targeting positive affect (extraversion). For example, in
an experience-sampling study, Mata et al. (2012) found
that both participants diagnosed with major depressive
disorder and control participants reported increases in
positive affect directly following physical activity and
that depressed participants in particular demonstrated
a dose-response effect such that longer and more
intense instances of physical activity led to greater
increases in positive affect. Speisman, Kumar, Rani,
Foster, and Ormerod (2012) recently demonstrated in
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
The Nature, Diagnosis, and Treatment of Neuroticism 357
animal laboratories that exercise increases neurogenesis,
which could possibly be one mechanism of action in suc-
cessful psychological treatments using exercise. Despite
strong preliminary evidence, this theory must now
undergo the slow process of scientific confirmation.
Given the clinical promise of therapeutically address-
ing temperamental vulnerabilities, we have devoted more
than a decade to developing a psychological treatment
that targets the putative, fundamental, underlying pro-
cesses of anxiety and mood disorders that may be more
closely related to temperament. This treatment, the uni-
fied protocol for transdiagnostic treatment of emotional
disorders (UP), which has been described in detail else-
where (Barlow et al., 2011), is a cognitive-behavioral
intervention designed to address core temperamental
processes in emotional disorders. The UP targets identifi-
cation and modification of the strong negative reactions
to emotions that lead to problematic, avoidant coping
across emotional disorders (Ellard, Fairholme, Boisseau,
Farchione, & Barlow, 2010). Amelioration of negative
reactions to emotions in turn changes the frequency and
intensity of future emotional experiences and thereby
affects temperamental constructs.
The UP has now been evaluated for its efficacy in
treating anxiety disorders in a series of preliminary trials
culminating with a small randomized controlled trial (N =
37) comparing a treatment group with a wait list control
group (Ellard et al., 2010; Farchione et al., 2012). Results
from these studies have indicated that the UP is an effica-
cious treatment for a range of anxiety disorders with sta-
ble improvements out to an 18-month follow-up (Bullis,
Fortune, Farchione, & Barlow, 2013). We have also
recently begun a large randomized controlled equiva-
lence trial (N = 250) comparing the UP with four well-
established single anxiety disorder treatment protocols
on the basis of patients’ principal diagnoses (generalized
anxiety disorder, obsessive-compulsive disorder, social
anxiety disorder, or panic disorder with or without
agoraphobia).
In following with the goal of assessing the extent to
which the UP addresses temperamental vulnerabilities in
addition to current symptoms, we have also conducted
an investigation of the effects of the UP on dimensions of
temperament (see Carl, Gallagher, Sauer-Zavala, Bentley,
& Barlow, 2013) in the context of the randomized con-
trolled trial mentioned in the previous paragraph (i.e.,
Farchione et al., 2012). In brief, our results indicated that
in the treatment group, compared with the wait list group,
the UP produced small to moderate effects on both neu-
roticism and extraversion from pre- to posttreatment, and
these changes in temperament are associated with
improvements in core symptomatology, functional
impairment, and quality of life (Carl et al., 2013). The
results of this investigation suggest the importance of
changes in temperament as they affect treatment out-
comes. Neuroticism and extraversion contributed to both
shared and distinct treatment outcomes. Decreased neu-
roticism at posttreatment and at 6-month follow-up pre-
dicted decreased anxiety and depressive symptoms.
Increased extraversion was associated with decreased
depressive symptoms at posttreatment and decreased
anxiety symptoms at 6-month follow-up, and changes in
both temperament variables predicted reductions in
functional impairment at 6-month follow-up. Finally,
extraversion alone was associated with higher quality of
life at posttreatment and at 6-month follow-up. Although
preliminary, these results suggest that there are both
common and differentiated outcomes associated with
changes in specific dimensions of temperament. Although
both neuroticism and extraversion can affect depression
and anxiety symptoms and functional impairment, only
extraversion appears to directly influence quality of life.
In future research, it will be important to investigate and
gain a better understanding of what accounts for the vari-
ability in the effects of these temperamental predictors
on treatment outcomes.
In summary, contrary to traditional conceptions, a
variety of research has suggested that dimensions of tem-
perament may be malleable over time or in response to
treatment, but such findings have been mixed, which
indicates that more research is required to identify spe-
cific conditions that affect temperament. Specifically,
recently developed interventions that target dimensions
of temperament more directly have provided preliminary
support for the notion that psychological interventions
can address temperamental vulnerabilities and that such
improvements are associated with a range of beneficial
treatment outcomes (Carl et al., 2013; Farchione et al.,
2012; Kennedy et al., 2009). If confirmed, these findings
may shift the focus of investigation into the nature, diag-
nosis, and treatment of emotional disorders.
Future Research Directions
The construct of neuroticism is almost as old as the study
of psychopathology itself, but recent developments
described herein suggest fresh, new directions for
research. Considered broadly, can we develop targeted
psychological interventions for neuroticism? If so, will
these interventions provide a more efficient and effective
way to affect the broad sweep of phenomena across the
spectrum of emotional disorders, including common pat-
terns of comorbidity and subthreshold symptomatic pre-
sentations? Will these conceptions move us further along
toward the goal of a more satisfactory dimensional sys-
tem for classifying the emotional disorders and facilitate
the development of diagnostic instruments that will
greatly simplify the process of assessment? And can we
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
358 Barlow et al.
usefully extend these research objectives to other rele-
vant temperaments, such as positive affect and perhaps
constraint? The accumulation of important basic research
covered briefly in this review suggests that it may now be
possible to translate these concepts into a fundamentally
new approach to the diagnosis, assessment, and treat-
ment of emotional disorders.
Author Contributions
D. H. Barlow developed the main thesis of the manuscript.
D. H. Barlow, S. Sauer-Zavala, J. R. Carl, J. R. Bullis, and K. K.
Ellard all contributed substantially to the literature review and
subsequent drafting of the manuscript in support of this thesis.
Acknowledgments
Portions of this article were presented by D. H. Barlow as the
James McKeen Cattell Address at the Annual Meeting of the
Association for Psychological Science, May 2012.
Declaration of Conflicting Interests
The authors declared that they had no conflicts of interest with
respect to their authorship or the publication of this article.
Note
1. We henceforth refer to this construct as neuroticism; how-
ever, it should be noted that the individual studies described
may have used alternate terms.
References
Abramowitz, J., Tolin, D., & Street, G. (2001). Paradoxical effects
of thought suppression: A meta-analysis of controlled stud-
ies. Clinical Psychology Review, 21, 683–703.
Aldao, A., Nolen-Hoeksema, S., & Schweizer, S. (2010).
Emotion-regulation strategies across psychopathology: A
meta-analytic review. Clinical Psychology Review, 30, 217–
237. doi:10.1016/j.cpr.2009.11.004.
Allen, L. B., White, K. S., Barlow, D. H., Shear, K. M., Gorman,
J. M., & Woods, S. W (2010). Cognitive-behavior therapy
(CBT) for panic disorder: Relationship of anxiety and
depression comorbidity with treatment outcome. Journal of
Psychopathology and Behavioral Assessment, 32, 185–192.
American Psychiatric Association. (1980). Diagnostic and sta-
tistical manual of mental disorders (3rd ed.). Washington,
DC: Author.
American Psychiatric Association. (2000). Diagnostic and sta-
tistical manual of mental disorders (4th ed., text rev.).
Washington, DC: Author.
American Psychiatric Association. (2013). Diagnostic and statis-
tical manual of mental disorders (5th ed.). Arlington, VA:
American Psychiatric Publishing.
Andrews, G. (1990). Classification of neurotic disorders. Journal
of the Royal Society of Medicine, 83, 606–607.
Andrews, G. (1996). Comorbidity in neurotic disorders: The
similarities are more important than the differences. In
R. M. Rapee (Ed.), Current controversies in the anxiety dis-
orders (pp. 3–20). New York, NY: Guilford Press.
Baer, R. A., Smith, G. T., Hopkins, J., Kritemeyer, J., & Toney,
L. (2006). Using self-report assessment methods to explore
facets of mindfulness. Assessment, 13, 27–45.
Baker, R., Holloway, J., Thomas, P., Thomas, S., & Owens,
M. (2004). Emotional processing and panic. Behaviour
Research and Therapy, 42, 1271–1287.
Barlow, D. H. (1988). Anxiety and its disorders: The nature and
treatment of anxiety and panic. New York, NY: Guilford
Press.
Barlow, D. H. (1991). Disorders of emotion. Psychological
Inquiry, 2, 58–71.
Barlow, D. H. (1996). The effectiveness of psychotherapy:
Science and policy. Clinical Psychology: Science and
Practice, 3, 236–240.
Barlow, D. H. (2000). Unraveling the mysteries of anxiety
and its disorders from the perspective of emotion theory.
American Psychologist, 55, 1247–1263.
Barlow, D. H. (2002). Anxiety and its disorders: The nature and
treatment of anxiety and panic (2nd ed.). New York, NY:
Guilford Press.
Barlow, D. H. (2004). Psychological treatments. American
Psychologist, 59, 869–878.
Barlow, D. H. (2008). Clinical handbook of psychological dis-
orders: A step-by-step treatment manual (4th ed.). London,
England: Oxford University Press.
Barlow, D. H., Cohen, A. S., Waddell, M. T., Vermilyea, B. B.,
Klosko, J. S., Blanchard, E. B., & DiNardo, P. A. (1984).
Panic and generalized anxiety disorders: Nature and treat-
ment. Behavior Therapy, 15, 431–449.
Barlow, D. H., Ellard, K. K., Fairholme, C., Farchione, T. J.,
Boisseau, C., Allen, L., & Ehrenreich-May, J. (2011). Unified
protocol for the transdiagnostic treatment of emotional dis-
orders. New York, NY: Oxford University Press.
Barlow, D. H., Ellard, K. K., Sauer-Zavala, S., Bullis, J. R., & Carl,
J. R. (2013). The origins of trait neuroticism. Manuscript in
preparation.
Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W.
(2000). Cognitive-behavioral therapy, imipramine, or their
combination for panic disorder: A randomized controlled
trial. Journal of the American Medical Association, 283,
2529–2536.
Begotka, A., Woods, D., & Wetterneck, C. (2004). The rela-
tionship between experiential avoidance and the sever-
ity of trichotillomania in a nonreferred sample. Journal of
Behavior Therapy and Experimental Psychiatry, 35, 17–24.
Berking, M., Neacsiu, A., Comtois, K., & Linehan, M. (2009).
The impact of experiential avoidance on the reduction of
depression in treatment for borderline personality disorder.
Behaviour Research and Therapy, 47, 663–670.
Biederman, J., Hirshfeld-Becker, D., Rosenbaum, J., Herot, C.,
Friedman, D., Snidman, N., . . . Farone, S. (2001). Further
evidence of the association between behavioral inhibi-
tion and social anxiety in children. American Journal of
Psychiatry, 158, 1673–1679.
Biederman, J., Rosenbaum, J. F., Bolduc-Murphy, E. A., Faraone,
S. V., Chaloff, J., Hirshfeld, D. R., & Kagan, J. (1993). A
3-year follow-up of children with and without behavioral
inhibition. Journal of the American Academy of Child and
Adolescent Psychiatry, 32, 814–821.
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
The Nature, Diagnosis, and Treatment of Neuroticism 359
Biederman, J., Rosenbaum, J., Hirshfeld, D., & Faraone, S.
(1990). Psychiatric correlates of behavioral inhibition in
young children of parents with and without psychiatric dis-
orders. Archives of General Psychiatry, 47, 21–26.
Blair, K., Shaywitz, J., Smith, B. W., Rhodes, R., Geraci, M.,
Jones, M., . . . Pine, D. S. (2008). Response to emotional
expressions in generalized social phobia and generalized
anxiety disorder: Evidence for separate disorders. American
Journal of Psychiatry, 165, 1193–1202. doi:10.1176/appi
.ajp.2008.0707106
Boelen, P., Vrinssen, I., & van Tulder, F. (2010). Intolerance of
uncertainty in adolescents: Correlations with worry, anxi-
ety, social anxiety, and depression. Journal of Nervous and
Mental Disease, 198, 194–200.
Borkovec, T. D., Abel, J. L., & Newman, H. (1995). Effects
of psychotherapy on comorbid conditions in general-
ized anxiety disorder. Journal of Consulting and Clinical
Psychology, 63, 479–483.
Boswell, J. F., Farchione, T. J., Sauer-Zavala, S. E., Murray, H.
W., Fortune, M., & Barlow, D. H. (2013). Anxiety sensitiv-
ity and interoceptive exposure: A transdiagnostic construct
and change strategy. Behavior Therapy, 44, 417–431.
Boswell, J. F., Thompson-Hollands, J., Farchione, T. J., &
Barlow, D. H. (2013). Intolerance of uncertainty: A com-
mon factor in the treatment of emotional disorders. Journal
of Clinical Psychology, 69, 630–645. doi:10.1002/jclp.21965
Bouton, M., Mineka, S., & Barlow, D. H. (2001). Modern learn-
ing theory perspective on the etiology of panic disorder.
Psychological Review, 108, 4–32.
Brown, K., & Ryan, R. (2003). The benefits of being pres-
ent: Mindfulness and its role in psychological well-being.
Journal of Personality and Social Psychology, 84, 822–848.
Brown, K., Weinstein, N., & Creswell, D. (2011). Trait mind-
fulness modulates neuroendocrine and affective responses
to social-evaluative threat. Psychoneuroendocrinology, 37,
2037–2041.
Brown, T. A. (2007). Temporal course and structural relation-
ships among dimensions of temperament and DSM–IV anx-
iety and mood disorder constructs. Journal of Abnormal
Psychology, 116, 313–328.
Brown, T. A., Antony, M. M., & Barlow, D. H. (1995). Diagnostic
comorbidity in panic disorder: Effect on treatment outcome
and course of comorbid diagnoses following treatment.
Journal of Consulting and Clinical Psychology, 63, 408–418.
Brown, T. A., & Barlow, D. H. (1995). Long-term outcome in
cognitive-behavioral treatment of panic disorder: Clinical
predictors and alternative strategies for assessment. Journal
of Consulting and Clinical Psychology, 63, 754–765.
Brown, T. A., & Barlow, D. H. (2002). Classification of anxiety
and mood disorders. In D. H. Barlow (Ed.), Anxiety and its
disorders: The nature and treatment of anxiety and panic
(2nd ed., pp. 292–327). New York, NY: Guilford Press.
Brown, T. A., & Barlow, D. H. (2005). Dimensional versus cat-
egorical classification of mental disorders in the fifth edition
of Diagnostic and Statistical Manual of Mental Disorders
and beyond: Comment on the special section. Journal of
Abnormal Psychology, 114, 551–556.
Brown, T. A., & Barlow, D. H. (2009). A proposal for a dimen-
sional classification system based on the shared features of
the DSM-IV anxiety and mood disorders: Implications for
assessment and treatment. Psychological Assessment, 21,
256–271.
Brown, T. A., Campbell, L. A., Lehman, C. L., Grisham, J. R., &
Mancill, R. B. (2001). Current and lifetime comorbidity of
the DSM-IV anxiety and mood disorders in a large clinical
sample. Journal of Abnormal Psychology, 110, 49–58.
Brown, T. A., Chorpita, B. F., & Barlow, D. H. (1998). Structural
relationships among dimensions of the DSM-IV anxiety and
mood disorders and dimensions of negative affect, posi-
tive affect, and autonomic arousal. Journal of Abnormal
Psychology, 107, 179–192.
Brown, T. A., & McNiff, J. (2009). Specificity of autonomic
arousal to DSM-IV panic disorder and post-traumatic
stress disorder. Behaviour Research and Therapy, 47,
487–493.
Brown, T. A., & Rosellini, A. J. (2011). The direct and interac-
tive effects of neuroticism and life stress on the severity and
longitudinal course of depression. Journal of Abnormal
Psychology, 120, 844–856.
Brozina, K., & Abela, J. (2006). Behavioral inhibition, anx-
ious symptoms, and depressive symptoms: A short-term
prospective examination of the diathesis-stress model.
Behaviour Research and Therapy, 44, 1337–1346.
Bullis, J. R., Fortune, M. R., Farchione, T. J., & Barlow,
D. H. (2013). Long-term outcome of the unified protocol
for the transdiagnostic treatment of emotional disorders.
Manuscript submitted for publication.
Butler, L., & Nolen-Hoeksema, S. (1994). Gender differences
in responses to depressed mood in a college sample. Sex
Roles, 30, 331–346.
Calmes, C., & Roberts, J. (2007). Repetitive thought and emo-
tional distress: Rumination and worry as prospective predic-
tors of depressive and anxious symptomatology. Cognitive
Therapy and Research, 31, 343–356.
Campbell-Sills, L., Barlow, D., Brown, T., & Hofman, S. (2006).
Acceptability and suppression of negative emotion in anxi-
ety and mood disorders. Emotion, 6, 587–595.
Campbell-Sills, L., Liverant, G. I., & Brown, T. A. (2004).
Psychometric evaluation of the behavioral inhibition/
behavioral activation scales in a large sample of outpatients
with anxiety and mood disorders. Psychological Assessment,
16, 244–254.
Carl, J. R., Gallagher, M. W., Sauer-Zavala, S. E., Bentley, K. H.,
& Barlow, D. H. (2013). A preliminary examination of the
effects of the unified protocol on temperament. Manuscript
submitted for publication.
Cash, M., & Whittingham, K. (2010). What facets of mindful-
ness contribute to psychological well-being and depressive,
anxious, and stress-related symptomatology? Mindfulness,
1, 177–182.
Cheavens, J., & Heiy, J. (2011). The differential roles of affect
and avoidance in major depressive and borderline person-
ality disorder symptoms. Journal of Social and Clinical
Psychology, 30, 441–457.
Cheavens, J., Rosenthal, M., Daughters, S., Novak, J., Kosson,
D., & Lynch, T. (2005). An analogue investigation of the
relationships among perceived parental criticism, nega-
tive affect, and borderline personality disorder features:
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
360 Barlow et al.
The role of thought suppression. Behaviour Research and
Therapy, 43, 257–268.
Chorpita, B. F., Albano, A. M., & Barlow, D. H. (1998). The
structure of negative emotions in a clinical sample of chil-
dren and adolescents. Journal of Abnormal Psychology,
107, 74–85.
Chorpita, B. F., Brown, T. A., & Barlow, D. H. (1998). Perceived
control as a mediator of family environment in etiologi-
cal models of childhood anxiety. Behavior Therapy, 29,
457–476.
Clark, D. M. (1986). A cognitive approach to panic. Behaviour
Research and Therapy, 24, 461–470.
Clark, L. A. (2005). Temperament as a unifying basis for per-
sonality and psychopathology. Journal of Abnormal
Psychology, 114, 505–521.
Clark, L. A. (2009). Stability and change in personality disorder.
Current Directions in Psychological Science, 18, 27–31.
Clark, L. A., Vittengl, J., Kraft, B., & Jarrett, D. (2003). Separate
personality traits from states to predict depression. Journal
of Personality Disorders, 17, 152–172.
Clark, L. A., & Watson, D. (1991). Tripartite model of anxiety and
depression: Psychometric evidence and taxonomic implica-
tions. Journal of Abnormal Psychology, 103, 103–116.
Clark, L. A., & Watson, D. (2008). Temperament: An organizing
paradigm for trait psychology. In O. P. John, R. R. Robins,
& L. A. Pervin (Eds.), Handbook of personality: Theory and
research (3rd ed.). New York, NY: Guilford Press.
Clark, L. A., Watson, D., & Mineka, S. (1994). Temperament,
personality, and the mood and anxiety disorders. Journal
of Abnormal Psychology, 103, 103–116.
Collimore, K., McCabe, R., Carelton, N., & Asmundson, G.
(2008). Media exposure and dimensions of anxiety sensitiv-
ity: Differential associations with PTSD symptom clusters.
Journal of Anxiety Disorders, 22, 1021–1028.
Cox, B., Enns, M., Walker, J., Kjernisted, K., & Pidlubny, S.
(2001). Psychological vulnerabilities in patients with major
depression versus panic disorder. Behaviour Research and
Therapy, 39, 567–573.
Cox, B., Taylor, S., & Enns, M. (1999). Fear of cognitive dys-
control in relation to depressive symptoms: Comparisons
between original and alternative measures of anxiety sen-
sitivity. Journal of Behavior Therapy and Experimental
Psychiatry, 30, 301–311.
Creswell, D., Way, B., Eisenberger, N., & Leiberman, M. (2007).
Neural correlates of dispositional mindfulness during affect
labeling. Psychosomatic Medicine, 69, 560–565.
Cuijpers, P., Smit, F., Penninx, B. W. J. H., de Graaf, R., ten
Have, M., & Beekman, A. T. F. (2010). Economic costs of
neuroticism: A population based study. Archives of General
Psychiatry, 67, 1086–1093.
Digman, J. (1990). Personality structure: Emergence of the five-
factor model. Annual Review of Psychology, 41, 417–440.
Eaton, N., Krueger, R., & Oltmanns, T. (2011). Aging and the
structure and long-term stability of the internalizing spec-
trum of personality and psychopathology. Psychology and
Aging, 26, 987–993.
Ellard, K. K., Fairholme, C. P., Boisseau, C. L., Farchione,
T. J., & Barlow, D. H. (2010). Unified protocol for the
transdiagnostic treatment of emotional disorders: Protocol
development and initial outcome data. Cognitive and
Behavioral Practice, 17, 88–101. doi:10.1016/j.cbpra.2009
.06.002
Etkin, A., Prater, K. E., Hoeft, F., Menon, V., & Schatzberg,
A. F. (2010). Failure of anterior cingulate activation and
connectivity with the amygdala during implicit regulation
of emotional processing in generalized anxiety disorder.
American Journal of Psychiatry, 167, 545–554. doi:10.1176/
appi.ajp.2009.09070931
Etkin, A., & Wager, T. D. (2007). Functional neuroimaging of
anxiety: A meta-analysis of emotional processing in PTSD,
social anxiety disorder, and specific phobia. American
Journal of Psychiatry, 164, 1476–1488. doi:10.1176/appi.
ajp.2007.07030504
Eysenck, H. J. (1947). Dimensions of personality. Oxford,
England: Kegan Paul.
Eysenck, H. J. (1961). The handbook of abnormal psychology.
New York, NY: Basic Books.
Eysenck, H. J. (1981). A model for personality. New York, NY:
Springer-Verlag.
Eysenck, H. J., & Eysenck, S. B. G. (1975). Manual of the
Eysenck Personality Questionnaire (adult and junior).
London, England: Hodder & Stoughton.
Farchione, T. J., Fairholme, C. P., Ellard, K. K., Boisseau, C. L.,
Thompson-Hollands, J., Carl, J., . . . Barlow, D. H. (2012).
Unified protocol for the transdiagnostic treatment of emo-
tional disorders: A randomized controlled trial. Behavior
Therapy, 43, 666–678.
Freud, S. (1924). Collected papers. New York, NY: International
Psychoanalytic Press.
Fu, C. H. Y., Williams, S. C. R., Cleare, A. J., Brammer, M. J.,
Walsh, N. D., Kim, J., . . . Bullmore, E. T. (2004). Attenuation
of the neural response to sad faces in major depression by
antidepressant treatment. Archives of General Psychiatry,
61, 877–889.
Gallagher, M. W., Payne, L. P., White, K. S., Shear, K. M., Woods,
S. W., Gorman, J. M., & Barlow, D. H. (2013). Mechanisms
of change in cognitive-behavioral therapy for panic disor-
der: The unique effects of self-efficacy and anxiety sensitiv-
ity. Manuscript submitted for publication.
Gershuny, B. S., & Sher, K. J. (1998). The relation between
personality and anxiety: Findings from a 3-year prospective
study. Journal of Abnormal Psychology, 107, 252–262.
Goldberg, L. (1993). The structure of phenotypic personality
traits. American Psychologist, 48, 26–34.
Gray, J. A. (1982). The neuropsychology of anxiety. New York,
NY: Oxford University Press.
Gray, J. A. (1991). The neuropsychology of temperament. In
J. Strelau & A. Angleitner (Eds.), Explorations in tempera-
ment: International perspectives in theory and measure-
ment (pp. 105–128). New York, NY: Plenum.
Gray, J. A., & McNaughton, N. (1996). The neuropsychology of
anxiety: A reprise. In D. A. Hope (Ed.), Nebraska Symposium
on Motivation: Vol. 43. Perspectives on Anxiety, Panic, and
Fear (pp. 61–134). Lincoln: University of Nebraska Press
Griffith, J. W., Zinbarg, R. E., Craske, M. G., Mineka, S., Rose,
R. D., Waters, A. M., & Sutton, J. M. (2010). Neuroticism
as a common dimension in the internalizing disorders.
Psychological Medicine, 40, 1125–1136.
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
The Nature, Diagnosis, and Treatment of Neuroticism 361
Harmer, C. J., Mackay, C. E., Reid, C. B., Cowen, P. J., &
Goodwin, G. M. (2006). Antidepressant drug treatment
modifies the neural processing of nonconscious threat
cues. Biological Psychiatry, 59, 816–820.
Harmer, C. J., O’Sullivan, U., Favaron, E., Massey-Chase, R.,
Ayres, R., Reinecke, A., . . . Cowen, P. J. (2009). Effect of
acute antidepressant administration on negative affective
bias in depressed patients. American Journal of Psychiatry,
166, 1178–1184.
Hayes, S. C., Luoma, J. B., Bond, F. W., Masuda, A., & Lillis, J.
(2006). Acceptance and commitment therapy: Model, pro-
cesses and outcomes. Behaviour Research and Therapy,
44, 1–25.
Hayes, S. C., Wilson, K. G., Gifford, E. V., Follette, V. M., &
Strosahl, K. (1996). Experiential avoidance and behavioral
disorders: A functional dimensional approach to diag-
nosis and treatment. Journal of Consulting and Clinical
Psychology, 64, 1152–1168.
Hayward, C., Killen, J. D., Kraemer, H. C., & Taylor, C. B.
(1998). Linking self-reported childhood behavioral inhibi-
tion to adolescent social phobia. Journal of the American
Academy of Child and Adolescent Psychiatry, 37, 1308–
1316.
Heimberg, R. G., Liebowitz, M. R., & Hope, D. A. (1998).
Cognitive behavioral group therapy versus phenelzine
therapy for social phobia: 12-week outcome. Archives of
General Psychiatry, 55, 1133–1141.
Helson, R., Jones, C., & Kwan, V. S. (2002). Personality change
over 40 years of adulthood: Hierarchical linear modeling
analyses of two longitudinal samples. Journal of Personality
and Social Psychology, 83, 752–766.
Hirshfeld-Becker, D. R., Biederman, J. F., Henin, A., Faraone,
S. V., Davis, S., Harrington, K., & Rosenbaum, J. (2007).
Behavioral inhibition in preschool children at risk is a spe-
cific predictor of middle childhood social anxiety: A five-
year follow-up. Journal of Developmental and Behavioral
Pediatrics, 28, 225–233.
Hirshfeld-Becker, D. R., Rosenbaum, J. F., Biederman, J. F.,
Bolduc, E. A., Faraone, S. V., Snidman, N., . . . Kagan, J.
(1992). Stable behavioral inhibition and its association with
anxiety disorder. Journal of the American Academy of Child
and Adolescent Psychiatry, 31, 103–111.
Hoehn-Saric, R., Schlund, M. W., & Wong, S. H. Y. (2004). Effects
of citalopram on worry and brain activation in patients with
generalized anxiety disorder. Psychiatry Research, 131, 11–
21. doi:10.1016/j.pscychresns.2004.02.003
Hofmann, S. G., Heering, S., Sawyer, A. T., & Asnaani, A.
(2009). How to handle anxiety: The effects of reap-
praisal, acceptance, and suppression strategies on anxious
arousal. Behaviour Research and Therapy, 47, 389–394.
doi:10.1016/j.brat.2009.02.010
Holmes, A. J., Lee, P. H., Hollinshead, M. O., Bakst, L., Roffman,
J. L., Smoller, J. W., & Buckner, R. I. (2012). Individual dif-
ferences in amygdala-medial prefrontal anatomy link nega-
tive affect, impaired social functioning, and polygenetic
depression link. Journal of Neuroscience, 32, 18087–18100.
Hong, R. Y. (2007). Worry and rumination: Differential associa-
tions with anxious and depressive symptoms and coping
behavior. Behaviour Research and Therapy, 45, 277–290.
Hudson, J. I., & Pope, H. G. (1990). Affective spectrum disor-
der: Does antidepressant response identify a family of dis-
orders with a common pathophysiology? American Journal
of Psychiatry, 147, 552–564.
John, O. P. (1990). The “Big Five” factor taxonomy: Dimensions
of personality in the natural language and in questionnaires.
In L. A. Pervin (Ed.), Handbook of personality: Theory and
research (pp. 66–100). New York, NY: Guilford Press.
John, O. P., & Srivastava, S. (1999). The Big Five trait taxonomy:
History, measurement, and theoretical perspectives. In
L. A. Pervin & O. P. John (Eds.), Handbook of personality:
Theory and research (2nd ed., pp. 102–138). New York,
NY: Guilford Press.
Jylhä, P., & Isometsä, E. (2006). The relationship of neuroticism
and extraversion to symptoms of anxiety and depression in
the general population. Depression and Anxiety, 23, 281–289.
Kabat-Zinn, J. (1982). An outpatient program in behavioral
medicine for chronic pain patients based on the practice
of mindfulness meditation: Theoretical considerations and
preliminary results. General Hospital Psychiatry, 4, 33–47.
Kagan, J. (1989). Temperamental contributions to social behav-
ior. American Psychologist, 44, 668–674.
Kagan, J. (1994). Galen’s prophecy: Temperament in human
nature. New York, NY: Basic Books.
Kagan, J., & Snidman, N. (1991). Infant predictors of inhibited
and uninhibited profiles. Psychological Science, 2, 40–44.
Kasch, K. L., Rottenberg, J., Arnow, B. A., & Gotlib, I. H.
(2002). Behavioral activation and inhibition systems and
the severity and course of depression. Journal of Abnormal
Psychology, 111, 589–597.
Kashdan, T. B., Breen, W. E., Afram, A., & Terhar, D. (2010).
Experiential avoidance in idiographic, autobiographi-
cal memories: Construct validity and links to social anxi-
ety, depressive, and anger symptoms. Journal of Anxiety
Disorders, 24, 528–534.
Keightley, M. L., Seminowicz, D. A., Bagby, R. M., Costa, P. T.,
Fossati, P., & Mayberg, H. S. (2003). Personality influences
limbic-cortical interactions during sad mood induction.
NeuroImage, 20, 2031–2039.
Kendell, R. E. (1975). The role of diagnosis in psychiatry.
Oxford, England: Blackwell Scientific.
Kennedy, S. J., Rapee, R. M., & Edwards, S. L. (2009). A selective
intervention program for inhibited preschool-aged children
of parents with an anxiety disorder: Effects on current anxi-
ety disorders and temperament. Journal of the American
Academy of Child and Adolescent Psychiatry, 48, 602–609.
doi:10.1097/CHI.0b013e31819f6fa9
Kessler, R. C., Berglund, P., & Demler, O. (2003). The epide-
miology of major depressive disorder: Results from the
National Comorbidity Survey Replication (NCS-R). Journal
of the American Medical Association, 289, 3095–3105.
Kessler, R. C., Cox, B. J., Green, J. G., Ormel, J., McLaughlin,
K. A., Merikangas, K. R., . . . Zaslavsky, A. M. (2011). The
effects of latent variables in the development of comor-
bidity among common mental disorders. Depression and
Anxiety, 28, 29–39.
Kessler, R. C., Gruber, M., Hettema, J. M., Hwang, I., Sampson,
N., & Yonkers, K. A. (2008). Comorbid major depres-
sion and generalized anxiety disorders in the National
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
362 Barlow et al.
Comorbidity Survey follow-up. Psychological Medicine, 38,
365–374.
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Lui, J., Swartz,
M., & Blazer, D. G. (1996). Comorbidity of DSM-III-R major
depressive disorder in the general population: Results
from the National Comorbidity Survey. British Journal of
Psychiatry, 168, 17–30.
Kessler, R. C., Stang, P. E., Wittchen, H. U., Ustun, T. B., Roy-
Byrne, P. P., & Walters, E. E. (1998). Lifetime panic-depres-
sion comorbidity in the National Comorbidity Survey.
Archives of General Psychiatry, 55, 801–808.
Kotov, R., Watson, D., Robles, J. P., & Schmidt, N. B. (2007).
Personality traits and anxiety symptoms: The multilevel
trait predictor model. Behaviour Research and Therapy, 45,
1485–1503.
Krueger, R. F. (1999). The structure of common mental disor-
ders. Archives of General Psychiatry, 56, 921–926.
Lahey, B. B. (2009). Public health significance of neuroticism.
American Psychologist, 64, 241–256.
Lee, J. K., Orsillo, S. M., Roemer, L., & Allen, L. B. (2010).
Distress and avoidance in generalized anxiety disorder:
Exploring relationships with intolerance of uncertainty and
worry. Cognitive Behaviour Therapy, 39, 126–136.
Lewis, A. (1970). The ambiguous word “anxiety.” International
Journal of Psychiatry, 9, 62–79.
Lilienfeld, S. O. (1999). Anxiety sensitivity and the structure of
personality. In S. Taylor (Ed.), Anxiety sensitivity: Theory,
research and treatment of the fear of anxiety (pp. 149–182).
Mahwah, NJ: Erlbaum.
Lorberbaum, J. P., Kose, S., Johnson, M. R., Arana, G. W.,
Sullivan, L. K., Hamner, M. B., . . . George, M. S. (2004).
Neural correlates of speech anticipatory anxiety in general-
ized social phobia. NeuroReport, 15, 2701–2705.
Lyubomirsky, S., & Nolen-Hoeksema, S. (1995). Effects of self-
focused rumination on negative thinking and interper-
sonal problem solving. Journal of Personality and Social
Psychology, 69, 176–190.
Lyubomirsky, S., Tucker, K., Caldwell, N., & Berg, K. (1999).
Why ruminators are poor problem solvers: Clues from
the phenomenology of dysphoric rumination. Journal of
Personality and Social Psychology, 77, 1041–1060.
Maack, D. J., Tull, M. T., & Gratz, K. L. (2012). Experiential
avoidance mediates the association between behavioral
inhibition and posttraumatic stress disorder. Cognitive
Therapy and Research, 36, 407–416.
MacLeod, C., & Mathews, A. (2012). Cognitive bias modifica-
tion approaches to anxiety. Annual Review of Clinical
Psychology, 8, 189–217.
Maller, R. G., & Reiss, S. (1992). Anxiety sensitivity in 1984
and panic attacks in 1987. Journal of Anxiety Disorders, 6,
214–247.
Manos, R. C., Kanter, J. W., & Busch, A. M. (2010). A critical
review of assessment strategies to measure the behavioral
activation model of depression. Clinical Psychology Review,
30, 547–561.
Mata, J., Thompson, R. J., Jaeggi, S. M., Buschkuehl, M., Jonides,
J., & Gotlib, I. (2012). Walk on the bright side: Physical
activity and affect in major depressive disorder. Journal of
Abnormal Psychology, 121, 297–308. doi:10.1037/a0023522
Mathews, A., & McLeod, C. (2005). A cognitive vulnerability to
emotional disorders. Annual Review of Clinical Psychology,
1, 167–195.
Mayberg, H. S., Liotti, B. M., Brannan, S. K., McGinnis, S.,
Mahurin, R. K., Jerabek, P. A., . . . Fox, P. T. (1999).
Reciprocal limbic-cortical function and negative mood:
Converging PET findings in depression and normal sad-
ness. American Journal of Psychiatry, 156, 675–682.
McCabe, C., Mishor, Z., Cowen, P. J., & Harmer, C. J. (2010).
Diminished neural processing of aversive and rewarding
stimuli during selective serotonin reuptake inhibitor treat-
ment. Biological Psychiatry, 67, 439–445.
McCrae, R. R., & Costa, P. T. (1987). Validation of the five-fac-
tor model of personality across instruments and observers.
Journal of Personality and Social Psychology, 52, 81–90.
McHugh, R. K., & Barlow, D. H. (2010). The dissemination and
implementation of evidence-based psychological treat-
ments: A review of current efforts. American Psychologist,
65, 73–84.
McLaughlin, K. A., Mennin, D. S., & Farach, F. J. (2007). The con-
tributory role of worry in emotion generation and dysregu-
lation in generalized anxiety disorder. Behaviour Research
and Therapy, 45, 1735–1752. doi:10.1016/j.brat.2006.12.004
McNally, R. J. (1996). Methodological controversies in the treat-
ment of panic disorder. Journal of Consulting and Clinical
Psychology, 64, 88–91.
Mennin, D. S., Heimberg, R. G., Turk, C. L., & Fresco, D. M.
(2005). Preliminary evidence for an emotion dysregulation
model of generalized anxiety disorder. Behaviour Research
and Therapy, 43, 1281–1310. doi:10.1016/j.brat.2004.08
.008
Merikangas, K. R., Zhang, H., & Aveneoli, S. (2003). Longitudinal
trajectories of depression and anxiety in a prospective com-
munity study. Archives of General Psychiatry, 60, 993–1000.
Meyer, B., Johnson, S. L., & Winters, R. (2001). Responsiveness
to threat and incentive in bipolar disorder: Relations of the
BIS/BAS scales with symptoms. Journal of Psychopathology
and Behavioral Assessment, 23, 133–143.
Mineka, S., Watson, D., & Clark, L. A. (1998). Comorbidity of
anxiety and unipolar mood disorders. Annual Review of
Psychology, 49, 377–412.
Moore, S. A., Zoellner, L. A., & Mollenholt, N. (2008). Are
expressive suppression and cognitive reappraisal associ-
ated with stress-related symptoms? Behaviour Research and
Therapy, 46, 993–1000. doi:10.1016/j.brat.2008.05.001
Mroczek, D., & Spiro, A. (2003). Modeling intraindividual
change in personality traits: Findings from the Normative
Aging Study. Journals of Gerontology Series B: Psychological
Sciences and Social Sciences, 58, 153–165.
Murphy, S. E., Yiend, J., Lester, K. J., Cowen, P. J., & Harmer,
C. J. (2009). Short-term serotonergic but not noradrenergic
antidepressant administration reduces attentional vigilance
to threat in healthy volunteers. International Journal of
Neuropsychopharmacology, 12, 169–179.
Naragon-Gainey, K. (2010). Meta analysis of the relations of
anxiety sensitivity to the depressive and anxiety disorders.
Psychological Bulletin, 136, 128–150.
Naragon-Gainey, K., Gallagher, M. W., & Brown, T. A. (2013).
Stable “trait” variance of temperament as a predictor of
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
The Nature, Diagnosis, and Treatment of Neuroticism 363
the temporal course of depression and social phobia.
Manuscript in preparation.
Nathan, P. E., & Gorman, J. M. (Eds.). (2007). A guide to
treatments that work (3rd ed.). London, England: Oxford
University Press.
Nemeroff, C. (2013). Psychoneuroimmunoendocrinology: The
biological basis of mind-body physiology and pathophysi-
ology. Depression and Anxiety, 30, 285–287. doi: 10.1002/
da.22110
Newman, M., & Llera, S. (2011). A novel theory of experien-
tial avoidance in generalized anxiety disorder: A review
and synthesis of research supporting a contrast avoidance
model of worry. Clinical Psychology Review, 31, 371–382.
Nolen-Hoeksema, S. (1991). Responses to depression and their
effects on the duration of depressive episodes. Journal of
Abnormal Psychology, 100, 569–582.
Nolen-Hoeksema, S. (2000). The role of rumination in depres-
sive disorders and mixed anxiety/depressive symptoms.
Journal of Abnormal Psychology, 109, 504–511.
Nolen-Hoeksema, S., Larson, J., & Grayson, C. (1999). Explaining
the gender difference in depressive symptoms. Journal of
Personality and Social Psychology, 77, 1061–1072.
Nolen-Hoeksema, S., Wisco, B. E., & Lyubomirsky, S. (2008).
Rethinking rumination. Perspectives on Psychological
Science, 3, 400–424.
Norton, G. R., Rockman, G. E., Ediger, J., Pepe, C., Goldberg,
S., Cox, B. J., & Asmundson, G. J. G. (1997). Anxiety sen-
sitivity and drug choice in individuals seeking treatment
for substance abuse. Behaviour Research and Therapy, 35,
859–862.
O’Connor, D. B, O’Connor, R. C., & Marshall, R. (2007).
Perfectionism and psychological distress: Evidence of
the mediating effects of rumination. European Journal of
Personality, 21, 429–452.
Oltmanns, T. F., & Balsis, S. (2011). Personality disorders in
later life: Questions about the measurement, course, and
impact of disorders. Annual Review of Clinical Psychology,
7, 321–349.
Paquette, V., Levesque, J., Mensour, B., Leroux, J. M., Beaudoin,
G., Bourgouin, P., & Beauregard, M. (2003). “Change the
mind and you change the brain”: Effects of cognitive-
behavioral therapy on the neural correlates of spider pho-
bia. NeuroImage, 18, 401–409.
Paulesu, E., Sambugaro, E., Torti, T., Danelli, L., Ferri, F.,
Scialfa, G., . . . Sassaroli, S. (2010). Neural correlates of
worry in generalized anxiety disorder and in normal con-
trols: A functional MRI study. Psychological Medicine, 40,
117–124. doi:10.1017/S0033291709005649
Phan, K. L., Fitzgerald, D. A., Nathan, P. J., & Tancer, M. E.
(2006). Association between amygdala hyperactivity
to harsh faces and severity of social anxiety in general-
ized social phobia. Biological Psychiatry, 59, 424–429.
doi:10.1016/j.biopsych.2005.08.012
Pickett, S. M., Lodis, C. S., Parkhill, M. R., & Orcutt, H. K.
(2012). Personality and experiential avoidance: A model of
anxiety sensitivity. Personality and Individual Differences,
53, 246–250. doi:10.1016/j.paid.2012.03.031
Plehn, K., & Peterson, R. A. (2002). Anxiety sensitivity as a
predictor of the development of panic symptoms, panic
attacks, and panic disorder: A prospective study. Journal
of Anxiety Disorders, 16, 455–473. doi:10.1016/S0887-6185
(02)00129-9
Porto, P. R., Oliveira, L., Mari, J., Volchan, E., Figueira, I., &
Ventura, P. (2009). Does cognitive behavioral therapy
change the brain? A systematic review of neuroimag-
ing in anxiety disorders. Journal of Neuropsychiatry and
Clinical Neurosciences, 21, 114–125. doi:10.1176/appi
.neuropsych.21.2.114
Purdon, C. (1999). Thought suppression and psychopathol-
ogy. Behaviour Research and Therapy, 37, 1029–1054.
doi:10.1016/S0005-7967(98)00200-9
Quilty, L. C., Meusel, L. A., & Bagby, R. M. (2008). Neuroticism
as a mediator of treatment response to SSRIs in major
depressive disorder. Journal of Affective Disorders, 111,
67–73. doi:10.1016/j.jad.2008.02.006
Rachman, S., & de Silva, P. (1978). Abnormal and normal
obsessions. Behaviour Research and Therapy, 16, 233–248.
doi:10.1016/0005-7967(78)90022-0
Rapee, R. M., Kennedy, S., Ingram, M., Edwards, S., & Sweeney,
L. (2005). Prevention and early intervention of anxiety disor-
ders in inhibited preschool children. Journal of Consulting
and Clinical Psychology, 73, 488–497. doi:10.1037/0022-
006X.73.3.488
Rapee, R. M., Kennedy, S. J., Ingram, M., Edwards, S. L., &
Sweeney, L. (2010). Altering the trajectory of anxiety in at-
risk young children. American Journal of Psychiatry, 167,
1518–1525. doi:10.1176/appi.ajp.2010.09111619
Rasmussen, M. K., & Pidgeon, A. M. (2011). The direct and
indirect benefits of dispositional mindfulness on self-
esteem and social anxiety. Anxiety, Stress and Coping: An
International Journal, 24, 227–233. doi:10.1080/10615806
.2010.515681
Rassin, E., Muris, P., Schmidt, H., & Merkelbach, H.
(2000). Relationship between thought action fusion, thought
suppression, and obsessive-compulsive symptoms: A
structural equation model approach. Behaviour Research
and Therapy, 38, 889–897. doi:10.1016/S0005-7967(99)
00104-7
Rassovsky, Y., Kushner, M. G., Schwarze, N. J., & Wangensteen,
O. D. (2000). Psychological and physiological predictors of
response to carbon dioxide challenge in individuals with
panic disorders. Journal of Abnormal Psychology, 109,
616–623. doi:10.1037//0021-843X.109.4.616
Reardon, J. M., & Williams, N. L. (2007). The specificity of
cognitive vulnerabilities to emotional disorders: Anxiety
sensitivity, looming vulnerability, and explanatory style.
Journal of Anxiety Disorders, 21, 625–643. doi:10.1016/j
.janxdis.2006.09.013
Reiss, S. (1991). Expectancy model of fear, anxiety, and panic.
Clinical Psychology Review, 11, 141–153. doi:10.1016/0272-
7358(91)90092-9
Reiss, S. (1997). Trait anxiety: It’s not what you think it is.
Journal of Anxiety Disorders, 11, 201–214. doi:10.1016/
S0887-6185(97)00006-6
Reiss, S., Peterson, R. A., Gursky, D. M., & McNally, R. J. (1986).
Anxiety sensitivity, anxiety frequency, and the prediction
of fearfulness. Behaviour Research and Therapy, 24, 1–8.
doi:10.1016/0005-7967(86)90143-9
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
364 Barlow et al.
Roberts, B. W., & Mroczeck, D. (2008). Personality trait change
in adulthood. Current Directions in Psychological Science,
17, 31–35. doi:10.1111/j.1467-8721.2008.00543.x
Roberts, B. W., Walton, K. E., & Viechtbauer, W. (2006).
Patterns of mean-level change in personality traits across
the life course: A meta-analysis of longitudinal stud-
ies. Psychological Bulletin, 132, 1–25. doi:10.1037/0033-
2909.132.1.1
Robinson, J. L., Kagan, J., Reznick, J. S., & Corley, R. (1992).
The heritability of inhibited and uninhibited behavior: A
twin study. Developmental Psychology, 28, 1030–1037.
doi:10.1037/0012-1649.28.6.1030
Roemer, L., Salters, K., Raffa, S., & Orsillo, S. M. (2005). Fear and
avoidance of internal experiences in GAD: Preliminary tests
of a conceptual model. Cognitive Therapy and Research,
29, 71–88. doi:10.1007/s10608-005-1650-2
Rosellini, A. J. (2013). Initial development and validation of a
dimensional classification system for the emotional disor-
ders (Unpublished doctoral dissertation). Boston University,
Boston, MA.
Rosellini, A. J., Lawrence, A., Meyer, J., & Brown, T. A. (2010).
The effects of extraverted temperament on agoraphobia
in panic disorder. Journal of Abnormal Psychology, 119,
420–426. doi:10.1037/a0018614
Sarin, S., Abela, J., & Auerbach, R. (2005). Response
styles theory of depression: A test of specificity and
causal mediation. Cognition & Emotion, 19, 751–761.
doi:10.1080/02699930441000463
Sauer, S. E., & Baer, R. A. (2009). Responding to negative inter-
nal experience: Relationships between acceptance and
change-based approaches and psychological adjustment.
Journal of Psychopathology and Behavioral Assessment, 31,
378–386. doi:10.1007/s10862-009-9127-3
Sauer-Zavala, S., Boswell, J. F., Gallagher, M. W., Bentley, K.
H., Ametaj, A., & Barlow, D. H. (2012). The role of negative
affectivity and negative reactivity to emotions in predicting
outcomes in the unified protocol for the transdiagnostic
treatment of emotional disorders. Behaviour Research and
Therapy, 50, 551–557. doi:10.1016/j.brat.2012.05.005
Schmidt, N. B., Keough, M. E., Timpano, K. R., & Richey, J. A.
(2008). Anxiety sensitivity profile: Predictive and incremen-
tal validity. Journal of Anxiety Disorders, 22, 1180–1189.
doi:10.1016/j.janxdis.2007.12.003
Schwartz, C. E., Snidman, N., & Kagan, J. (1999). Adolescent
social anxiety as an outcome of inhibited tempera-
ment in childhood. Journal of the American Academy
of Child and Adolescent Psychiatry, 38, 1008–1015.
doi:10.1097/00004583-199908000-00017
Segal, Z. V., Williams, J. M. G., & Teasdale, J. D. (2002).
Mindfulness-based cognitive therapy for depression: A new
approach to preventing relapse. New York, NY: Guilford
Press.
Segerstrom, S. C., Tsao, J. C. I., Alden, L. E., & Craske, M. G.
(2000). Worry and rumination: Repetitive thought as a con-
comitant and predictor of negative mood. Cognitive Therapy
and Research, 24, 671–688. doi:10.1023/A:1005587311498
Selby, E. A., Anestis, M. D., & Joiner, T. E. (2008). Understanding
the relationship between emotional and behavioral dys-
regulation: Emotional cascades. Behaviour Research and
Therapy, 46, 593–611. doi:10.1016/j.brat.2008.02.002
Shahar, B., & Herr, N. R. (2011). Depressive symptoms predict
inflexibly high levels of experiential avoidance in response
to daily negative affect: A daily diary study. Behaviour
Research and Therapy, 49, 676–681. doi:10.1016/j.brat
.2011.07.006
Shin, L. M., & Liberzon, I. (2010). The neurocircuitry of fear,
stress, and anxiety disorders. Neuropsychopharmacology,
35, 169–191. doi:10.1038/npp.2009.83
Shin, L. M., Wright, C. I., Cannistraro, P. A., Wedig, M. M.,
McMullin, K., Martis, B., . . . Rauch, S. L. (2005). A functional
magnetic resonance imaging study of amygdala and medial
prefrontal cortex responses to overtly presented fearful
faces in posttraumatic stress disorder. Archives of General
Psychiatry, 62, 273–281. doi:10.1001/archpsyc.62.3.273
Slater, E. (1943). The neurotic constitution: A statistical study of
two thousand neurotic soldiers. Journal of Neurology and
Psychiatry, 6, 1–16. doi:10.1136/jnnp.6.1-2.1
Small, B. J., Hertzog, C., Hultsch, D. F., & Dixon, R. A. (2003).
Stability and change in adult personality of 6 years:
Findings from the Victoria Longitudinal Study. Journals
of Gerontology Series B: Psychological Sciences and Social
Sciences, 58, 166–176. doi:10.1093/geronb/58.3.P166
Soskin, D. P., Carl, J. R., Alpert, J., & Fava, M. (2012).
Antidepressant effects on emotional temperament: Toward
a biobehavioral research paradigm for major depressive
disorder. CNS Neuroscience & Therapeutics, 18, 441–451.
doi:10.1111/j.1755-5949.2012.00318.x
Speisman, R. B., Kumar, A., Rani, A., Foster, T. C., & Omerod,
B. K. (2012). Daily exercise improves memory, stimulates
hippocampal neurogenesis and modulates immune and
neuroimmune cytokines in aging rats. Brain, Behavior, and
Immunity, 28, 25–43.
Spijker, J., de Graf, R., Oldehinkel, A. J., Nolen, W. A., & Ormel,
J. (2007). Are the vulnerability effects of personality and
psychosocial functioning on depression accounted for by
subthreshold symptoms? Depression and Anxiety, 24, 472–
478. doi:10.1002/da.20252
Straube, T., Mentzel, H. J., & Miltner, W. H. (2006). Neural
mechanisms of automatic and direct processing of phobo-
genic stimuli in specific phobia. Biological Psychiatry, 59,
162–170. doi:10.1016/j.biopsych.2005.06.013
Strupp, H. (1973). The future of research in psychotherapy. In
H. Strupp (Ed.), Psychotherapy: Clinical, research, and the-
oretical issues (pp. 733–756). Lanham, MD: Jason Aronson.
doi:10.1037/11523-027
Tang, T. Z., DeRubeis, R. J., Hollon, S. D., Amsterdam, J.,
Shelton, R., & Schalet, B. (2009). Personality change during
depression treatment: A placebo-controlled trial. Archives
of General Psychiatry, 66, 1322–1330. doi:10.1001/archgen
psychiatry.2009.166
Taylor, S. (1999). Anxiety sensitivity: Theory, research and treat-
ment of the fear of anxiety. Mahwah, NJ: Erlbaum.
Tellegen, A. (1985). Structures of mood and personality and
their relevance to assessing anxiety, with an emphasis on
self-report. In A. H. Tuma & J. D. Maser (Eds.), Anxiety and
the anxiety disorders (pp. 681–706). Hillsdale, NJ: Erlbaum.
Tillfors, M., Furmark, T., Marteinsdottir, I., & Fredrikson, M.
(2002). Cerebral blood flow during anticipation of public
speaking in social phobia: A PET study. Biological Psychiatry,
52, 1113–1119. doi:10.1016/S0006-3223(02)01396-3
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from
The Nature, Diagnosis, and Treatment of Neuroticism 365
Tolin, D. F., Abramowitz, J. S., Brigidi, B. D., & Foa, E. B.
(2003). Intolerance of uncertainty in obsessive-compul-
sive disorder. Journal of Anxiety Disorders, 17, 233–242.
doi:10.1016/S0887-6185(02)00182-2
Tomarken, A. J., Dichter, G. S., Freid, C., Addington, S.,
& Shelton, R. C. (2004). Assessing the effects of bupro-
pion SR on mood dimensions of depression. Journal of
Affective Disorders, 78, 235–241. doi:10.1016/S0165-0327
(02)00306-3
Tsao, J. C. I., Lewin, M. R., & Craske, M. G. (1998). The effects of
cognitive-behavior therapy for panic disorders on comor-
bid conditions. Journal of Anxiety Disorders, 12, 357–371.
doi:10.1016/S0887-6185(98)00020-6
Tsao, J. C. I., Mystkowski, J. L., & Zucker, B. G. (2002). Effects
of cognitive-behavioral therapy for panic disorder on
comorbid conditions: Replication and extension. Behavior
Therapy, 33, 493–509. doi:10.1016/S0005-7894(02)80013-2
Tull, M. T., Gratz, K. L., Salters, K., & Roemer, L. (2004). The
role of experiential avoidance in posttraumatic stress symp-
toms and symptoms of depression, anxiety, and somatiza-
tion. Journal of Nervous and Mental Disease, 192, 754–761.
doi:10.1097/01.nmd.0000144694.30121.89
Tull, M. T., & Roemer, L. (2007). Emotion regulation difficulties
associated with the experience of uncued panic attacks:
Evidence of experiential avoidance, emotional nonaccep-
tance, and decreased emotional clarity. Behavior Therapy,
38, 378–391. doi:10.1016/j.beth.2006.10.006
Turk, C. L., Heimberg, R. G., Luterek, J. A., Mennin, D. S., &
Fresco, D. M. (2005). Emotion dysregulation in generalized
anxiety disorder: A comparison with social anxiety disorder.
Cognitive Therapy and Research, 29, 89–106. doi:10.1007/
s10608-005-1651-1
Tyrer, P. J. (1989). Classification of neurosis. Chichester,
England: John Wiley & Sons.
Watson, D. (2005). Rethinking mood and anxiety disorders:
A quantitative hierarchical model for DSM-V. Journal of
Abnormal Psychology, 114, 522–536. doi:10.1037/0021-
843X.114.4.522
Watson, D., & Clark, L. A. (1993). Behavioral disinhibition ver-
sus constraint: A dispositional perspective. In D. M. Wegner
& J. W. Pennebaker (Eds.), Handbook of mental control
(pp. 506–527). New York, NY: Prentice Hall.
Watson, D., Clark, L. A., & Carey, G. (1988). Positive and nega-
tive affectivity and their relation to anxiety and depressive
disorders. Journal of Abnormal Psychology, 97, 346–353.
doi:10.1037//0021-843X.97.3.346
Wegner, D. M., Schneider, D. J., Carter, S. R., & White, T. L.
(1987). The paradoxical effects of thought suppression.
Journal of Personality and Social Psychology, 53, 5–13.
doi:10.1037//0022-3514.53.1.5
Weiss, N. H., Tull, M. T., Davis, L. T., Dehon, E. E., Fulton, J. J.,
& Gratz, K. L. (2012). Examining the association between
emotion regulation difficulties and probable posttraumatic
stress disorder within a sample of African Americans.
Cognitive Behaviour Therapy, 41, 5–14. doi:10.1080/1650
6073.2011.621970
Widiger, T. A., & Crego, C. (2013). Diagnosis and classifica-
tion. In I. B. Weiner, G. Stricker, & T. A. Widiger (Eds.),
Handbook of psychology: Clinical psychology (2nd ed.,
pp. 3–18). Hoboken, NJ: John Wiley & Sons.
Widiger, T. A., Verheul, R., & van den Brink, W. (1999).
Personality and psychopathology. In L. A. Pervin & O. P.
John (Eds.), Handbook of personality: Theory and research
(2nd ed., pp. 347–366). New York, NY: Guilford Press.
Zinbarg, R. E., & Barlow, D. H. (1996). Structure of anxiety
and the anxiety disorders: A hierarchical model. Journal
of Abnormal Psychology, 105, 181–193. doi:10.1037/0021-
843X.105.2.181
by Jacqueline Bullis on June 18, 2014cpx.sagepub.comDownloaded from